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ABSTRACT 
Predicting Rupture, Death, and Dissection: The Natural History of Thoracic Aortic Disease 
Ryan R. Davies, Michael A. Coady, John A Rizzo1, John A. Elefteriades, 
Section of Cardiothoracic Surgery and fSchool of Epidemiology and Public Health 
Yale University School of Medicine, New Haven, CT 
Background - Thoracic aortic aneurysms and dissections are serious, potentially fatal diseases. Ability to 
estimate simply the yearly rate of rupture/dissection would greatly enhance clinical decision making for 
specific patients. 
Methods - Data on 668 patients (414m, 254f) (median age 65.8 yrs) with thoracic aortic disease was en¬ 
tered into a computerized database over nine years. 3115 imaging studies were available. 304 patients 
were dissection-free at presentation; their natural (unoperated) history was followed for rupture, dissection, 
and death. In order to assess the impact of familial clustering of aortic or aneurysmal disease, family pedi¬ 
grees were obtained through telephone inquiry of 218 (142m, 76f) patients without Marfan syndrome 
(MFS). 
Results - 5-year survival in unoperated patients was 54% at 5 years. Aortic size was a very strong pre¬ 
dictor of rupture, dissection, and mortality. For aneurysms a 6.0 cm in diameter: rupture occurred at 3.6% 
per year, rupture or dissection at 6.4% per year, death at 10.8%, and death, rupture or dissection at 14.1% 
per year. At size a 6.0 cm, the odds ratio for rupture was increased 15-fold {p = 0.0041). Elective, pre¬ 
emptive surgical repair restored life-expectancy to normal. Of 218 patients contacted, 44 (18.9%) had one 
or more first-order relatives with aneurysmal disease. Patients with non-MFS familial aggregation were 
similar to those with sporadic disease, but had a trend toward higher growth rates and mortality (odds ratio 
1.594, p = 0.5124). 
Conclusions - This study indicates that (1) Thoracic aneurysm is a lethal disease. (2) familial aggregation 
occurs in 19% of cases and may carry a worse prognosis (3) Aneurysm size has a profound impact on rup¬ 
ture, dissection and death. (4) For counseling purposes, the patient with an aneurysm exceeding 6 cm can 
expect a yearly rate of rupture or dissection of at least 6.4% and a death rate of 10.8%. (5) Elective surgical 
repair restores survival to near normal. This analysis strongly supports careful radiologic follow-up and 
elective, pre-emptive surgical intervention for the otherwise lethal condition of large thoracic aortic aneu¬ 
rysm. 

Davies et al. - The Natural History of Thoracic Aortic Disease Acknowledgements 
ACKNOWLEDGEMENTS 
I have worked on this project throughout my time in medical school, and it could not have been 
completed without the help and guidance of a substantial number of people. Obviously, I would like to 
thank my mentor, John Elefteriades, MD, Chief of the Section of Cardiothoracic Surgery. Invaluable 
guidance and assistance in all parts of this work was provided by Michael Coady, MD, MPH, who was a 
general surgery resident at Yale and has moved on to Stanford, CA to complete his training in thoracic sur¬ 
gery. In addition to first introducing me to the project, he provided day-to-day guidance in data collection, 
statistical analysis, and the writing of scientific articles. 
Other people who I should thank for their help include: Lee J. Goldstein, MD, and John A. Rizzo, 
PhD. I would also like to thank Graeme L. Hammond, M.D. for his close reading of the manuscript and his 
assistance in preparing the final version. Rhaea Miller has provided vital assistance throughout my time 
working with the Section of Cardiothoracic Surgery. The personnel in the laboratory of Richard P. Lifton, 
M.D., Ph.D., especially Dr. Lifton and Carol Nelson-Williams, have provided guidance on the genetic as¬ 
pects of the project and assistance in collecting DNA from patients. Personnel in the lab also performed the 
genetic analysis described below. 
Finally, I would like to thank my parents and family for their support throughout my education at 
Yale. 
Portions of the work described in this thesis were presented at: the 79th Annual Meeting of the 
New England Surgical Society, Toronto, ONT, Canada, Sept. 25th to 27th, 1998, the 71st Scientific Session 
of the American Heart Association, Atlanta, GA, Oct. 1998, and the 37th Annual Meeting of the Society of 
Thoracic Surgeons, New Orleans, LA, Jan. 29th to 31st, 2001, and published in prior form.1"5 
Portions of the work described in this thesis were funded by Grant-in-Aid CT-BP97-GR-45 from 
the American Heart Association, Dallas, Tex. 

Davies et aL - The Natural History of Thoracic Aortic Disease Acknowledgements 
Further portions were performed while the author was supported by a training grant in the form of 
a Medical Student Research Training Fellowship from the Howard Hughes Medical Institute, Chevy Chase, 
MD 

Davies et al. - The Natural History of Thoraac Aortic Disease Table of Contents 
TABLE OF CONTENTS 
Abstract.i 
Table of Contents.iv 
ables.vi 




Anatomy and Physiology of the Thoracic Aorta.1 
Structural Proteins of Arterial Walls.1 
The Structure of the orta.I 
Classification of Thoracic Aortic Disease.2 
Dissection.5 
Penetrating Ul er.4 
Intramural Hematoma.5 
Familial Aggregation.......6 
Thoracic Aortic Aneurysms.6 
History.6 
Etiol g .7 
Natural History.....7 
Treatment.12 
The Inheritance of Thoracic Aortic Disease.13 
Marfan Syndrome and Inherited Connective Tissue Disease.13 
Familial Inheritance irs Patients without Systemic Connective Tissue Disease. 14 
impact of Familial Aggregation on Natural History.14 
Statement of Purpose.............16 
Methods_..._____..........18 
Patients and Data Collection.18 
Initial Recruitment of Study Population.18 
Prospecti ve Recruitment of Study Population.18 
All .Patients. 19 
Statistical Analysis.22 
Growth Rate Analysts.22 
Analysis of Complication Rates in Thoracic Aortic Aneurysms.23 
Determination of Family History and Genetic Analysis.24 
Patient Collection and Data Analysis.. 24 
Genetic A alysis.26 
Results.........._................27 
Characteristics of the Entire Study Population.27 
Aneurysm Growth Rates.27 
Analysis of complications.29 
Demographic and Climes! Characteristics of the Study Population.29 
Complication R t s.30 
The Impact of Genetic Factors on Natural History.41 
Demographic and Clinical Characteristics of the Study Population.41 
iv 

Davies et al. - The Natural History of Thoradc Aortic Disease Table of Contents 
Pedigree Analysis. 
Aneurysm Growth Rates 
Long-Term Survival. 
Discussion. 
Aneurysm Growth Rates. 
Analysis of Complications. 












Davies et al. - The Natural History of Thoracic Aortic Disease Table of Tables 
TABLES 
Table 1. Classification of thoracic aortic aneurysm.3 
Table 2. Distribution of 92 end-points.21 
Table 3. Demographic characteristics of 668 patients with thoracic aortic disease.27 
Table 4. Multivariate estimates of aneurysm growth rates.28 
Table 5. Demographic information on 304 patients included in analysis of complications.29 
Table 6. Initial aortic size (cm) in 304 patients with thoracic aortic aneurysms.30 
Table 7. Aneurysm size (cm) at the time of complication.32 
Table 8. Univariate analysis of rupture and issection.33 
Table 9. Univariate analysis of rupture/dissection and eath.34 
Table 10. Logistic regression of risk factors for rupture or dissection (dependent variables).35 
Table 11. Proportional hazards regression of factors predicting increased rates of rupture or dissection. 
(dependent variables).36 
Table 12. Proportional hazards regression of factors predicting increased rates of rupture (dependent 
variables).37 
Table 13. Proportional hazards regression of factors predicting increased rates of complications (rupture, 
dissection or death) prior to surgery (dependent variables).39 
Table 14. Comparison of demographic patients between patients with known (+ or -) family history and 
those with unknown family history. (Numbers are percentages unless otherwise indicated).41 
Table 15. Demographics and clinical characteristics of patients with non-MFS-related familial thoracic 
aortic disease.42 
Table 16. Comparison of patients with sporadic, nMFS familial, and MFS-related aortic disease.43 
Table 17. Comparison of aortic growth rate according to dissection status in patients with sporadic, nMFS 
familial, and MFS-related thoracic aortic aneurysms. 44 
Table 18. Proportional hazards regression of factors predicting decreased long-term survival when familial 
history is included as a risk factor (dependent variables).45 
vi 

Davies et aL - The Natural History of Thoraac Aortic Disease Table of Figures 
FIGURES* 
Figure 1. Diagrammatic representations of the molecular structure of collagen.1 
Figure 2. Hypothetical mechanism for the stretching of elastin molecules. Adapted from Alberts et al.5.1 
Figure 3. Elastic van Gieson stained section of the an aorta (original magnification X 20).2 
Figure 4. Computed tomography (CT) of patient with a large aortic aneurysm. (A concomitant dissection 
is visible in the left posterior portion of the aorta).3 
Figure 5. A. The three layered aortic wall, the intima (red) lines the lumen, the adventitia (yellow) forms 
the external layer, and the media (pink) sits between. B. A tear through the intima allows a column of 
blood to split the layers of the edia.3 
Figure 6. Computerized tomography (CT) of a patient with a classic type B aortic dissection.3 
Figure 7. The classification of aortic dissection. Included with the Stanford classification is the incidence 
of intimal tears in each region of the aorta based on autopsy studies. Adapted from a diagram by 
Ergin and Griepp.31 4 
Figure 8. Diagram of PAU.4 
Figure 9. A. MR image (sagittal view) of a patient with a penetrating atherosclerotic ulcer. B. MR image 
(axial view) of a patient with a penetrating atherosclerotic ulcer.5 
Figure 10. Diagram of IMH.5 
Figure 11. Transthoracic echocardiogram (TEE) of a patient with an intramural hematoma.5 
Figure 12. Early depiction of Galen.6 
Figure 14. Estimated effect of aneurysm size on risk of complication (rupture or dissection) for 
ascending/arch and descending/thoraco-abdominal aneurysm location. Adapted from Coady et al.80... 10 
Figure 15. Pedigree of a family demonstrating aggregation of thoracic aortic disease identified by Nicod, 
et al.157 14 
Figure 16. Multivariable estimates of aneurysm growth rates by initial aortic size and location.27 




Davies et aL - The Natural History of Thoracic Aortic Disease Table of Figures 
Figure 18. Histogram of initial aortic size in 304 patients.29 
Figure 19. Incidence of acute dissection or rupture as a function of initial aneurysm size.30 
Figure 20. Incidence of rupture as a function of initial aneurysm size.31 
Figure 21. Incidence of acute dissection as a function of initial aneurysm size.31 
Figure 22. Kaplan-Meier cumulative incidence of rupture or dissection. Five-year hazard estimates are 
illustrated for patients as a function of initial aneurysms size, p = 0.006.36 
Figure 23. Average yearly rate of rupture or dissection by initial aortic size.36 
Figure 24. Average yearly rate of rupture by initial aortic size.37 
Figure 25. Kaplan-Meier cumulative incidence of rupture. Five-year hazard estimates are illustrated for 
patients as a function of initial aneurysm size, p = 0.0045.37 
Figure 26. Kaplan-Meier cumulative incidence of dissection. Five-year hazard estimates are illustrated for 
patients as a function of initial aneurysms size,/? = 0.1878.38 
Figure 27. Average yearly rate of dissection by initial aortic size.38 
Figure 28. Kaplan-Meier cumulative survival prior to operative repair. Five-year survival estimates are 
illustrated for patients as a function of initial aneurysm size, p = 0.0671.38 
Figure 29. Average yearly rate of death by initial aortic size.38 
Figure 30. Average yearly rate of rupture, dissection or death based on initial aortic size.38 
Figure 31. Average yearly rates of all negative outcomes by initial aortic size.39 
Figure 32. Kaplan-Meier cumulative survival. Five-year survival estimates are illustrated for patients as a 
function of initial aortic size, p = 0.0671 ...40 
Figure 33. Kaplan-Meier cumulative survival. Five-year survival estimates are illustrated for patients as a 
function of aneurysm location, p = 0.0023.40 
Figure 34. Kaplan-Meier cumulative survival. Five-year survival estimates are illustrated for patients as a 
function dissection status, p = 0.0002. 40 
Figure 35. Kaplan-Meier cumulative survival. Five-year survival estimates are illustrated for patients as a 
function of the treatment received,/? = 0.002...40 
Figure 36. Kaplan-Meier cumulative survival. Five-year post-operative survival estimates are illustrated 
for patients as a function of the urgency of the surgical procedure, p = 0.0004  40 
viii 

Davies et al. — The Natural History of Thoracic Aortic Disease Table of Figures 
Figure 37. Prevalence of comorbidities analyzed by the presence of a family history.43 
Figure 38. Pedigrees for 26 families with nMFS familial aortic disease.44 
Figure 39. Kaplan-Meier cumulative survival prior to operative repair. Five-year survival estimates are 
illustrated for patients as a function of familial history, (p = 0.997).45 
Figure 40. Kaplan-Meier cumulative survival. Five-year survival estimates are illustrated for patients as a 
function of familial history, (p = 0.0902).45 
Figure 41. Kaplan-Meier cumulative survival. Five-year survival estimates are illustrated for patients as a 
function of whether or not we were able to ascertain a family history, (p - 0.0003).46 
IX 

Davies et al. - The Natural History of Thoracic Aortic Disease Table of Equations 
EQUATIONS 
Equation 1. Traditional growth rate formula.8 
Equation 2. Griepp’s formula for prediction of rupture within one year of size measurement.11 
Equation 3. Multivariable estimation of aneurysm growth rates. 22 
Equation 4. Natural log of Equation 3.22 
Equation 5. Rearrange Equation 4. 3 
Equation 6. Estimated regression (IV estimation) for patients with and without chronic dissection.23 
Equation 7. Definition of growth rates.23 
Equation 8. Combine Equations 3 and 7.23 
Equation 9. Rearrange Equation 8.  

Davies et al. - The Natural History of Thoracic Aortic Disease Abbreviations 
ABBREVIATIONS 
The first appearance of an abbreviation occurs in parentheses following the full term. The fol¬ 
lowing table is provided for reference purposes: 
AAA abdominal aortic aneurysm 
CAD coronary artery disease 
CHF congestive heart failure 
Cl confidence interval 
CMN cystic medial necrosis 
CT computed tomography 
CVA cerebrovascular accident 
EDS-IV Ehlers-Danlos Syndrome Type IV 
F-AAA familial abdominal aortic aneurysm 
IEL internal elastic lamina 
IMH intramural hematoma 
MFS Marfan syndrome 
MRI magnetic resonance imaging 
nMFS familial non-Marfan syndrome-related familial 
PAU penetrating atherosclerotic ulcer 
SMC smooth muscle cell 
TAA thoracic aortic aneurysm 
TEE transesophageal echocardiogram 
TTE transthoracic echocardiogram 

Davies et al. - The Natural History of Thoracic Aortic Disease Introduction 
INTRODUCTION 
Anatomy and Physiology of the Thoracic Aorta 
Structural Proteins of Arterial Walls 
Collagen (especially types I and III) and 
elastin are the most important structural proteins in 
the aorta.6 7 Collagens consist of three polypeptide 
chains which coil around each other to form three- 
stranded ropes or collagen fibrisf^ (Figure 1) which 
aggregate into “cable-like” collagen fibers .5 
Secreted elastin molecules, on the other 
hand, form extensive cross-links to generate a net¬ 
work of fibers and sheets. The exact mechanism for 
their subsequent elasticity is not completely under¬ 
stood, but Figure 2 illustrates one hypothesis. The 
elastin core of the clastic fiber is covered in a sheath 
of microfibrils. The microfibrillar proteins appear to 
act as scaffolding for the subsequent deposition of 
elastin, and may also play a role in tissue homeosta¬ 
sis.510,11. They include fibrillin-1, whose encoding 
gene, FBN1, has been identified as the defective 
gene in Marfan syndrome (MFS).1’ 
The Structure of the Aorta 
The aorta is an elastic artery with three de¬ 
fined layers: the intima, media and adventitia. 
(Figure 3) The intima consists of a single layer of 
endothelial cells supported by a layer of collagenous 
Figure 1. Diagrammatic representations of the molecular structure of 
collagen. (A) An individual a-chain composed of triplet repeats (Gly-X- 
Y), X and Y are usually (but not necessarily) proline and hydoxyproline. 
(B) A completed collagen fibril, a left-handed triple helix formed of 
three u-chains (in different colors). Only the glycine molecule is small 




Figure 2. Hypothetical mechanism for the stretching of elastin molecules 
The elastin molecules are shown in green joined together by the covalent 
cross-links (red) to form a network. When relaxed, they form a loose 
conglomeration of fibers (upper image), but when stretched, adopt a linear 
structure. Adapted from Alberts et al.5 
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tissue rich in clastin. This subendothelial tissue also 
contains fibroblasts and cells similar to smooth muscle 
cells (SMC) known as myointimal cells; these two cells 
types are both thought to contribute to the elaboration of 
extra-cellular components. 
The media is a broad, highly elastic layer com¬ 
posed of SMC within a matrix of clastin, collagen, and Figure 3. Elastic van Gieson stained section of the aorta (original 
magnification X 20) demonstrating the internal elastic lamina (IEL) 
delineating the intima from the media (M). The IEL (composed of 
ground substance. The elastic fibers are arranged as elastin), has fenestrae that allow substances to diffuse to nourish 
cells deep within the aortic wall. The media comprises a mixture of 
smooth muscle cells and reticular and elastic fibers. The adventitia 
circumferential lamallae. In the thoracic aorta there are (A) and the outer part of the media have small blood vessels (vasa 
vasorum) and elastic and collagenous fibers. 
approximately 45 to 56 lamallae, whereas the abdominal aorta contains only 28.13-15 This may contribute to 
the higher prevalence of abdominal aortic aneurysm (AAA) compared to thoracic aortic aneurysm (TAA).16 
The elastic lamellae play a central role in circulatory physiology: during systole, the diameter of 
the lamellae increase, then, during diastole, the elastic fibers recoil: maintaining forward blood flow during 
diastole.17 Thus the elastic fibers function as shock absorbers for the kinetic energy of the fluid shockwave 
which strikes the aortic wall with each cardiac contraction.1*211 The medial SMC control vascular resis¬ 
tance, perform a macrophage-like function, and secrete collagen into the extracellular matrix/1 Deposition 
of collagen continues throughout life, but humans are unable to synthesize elastic fibers in adulthood —little 
elastin synthesis can be detected after infancy.22 
The adventitial layer surrounds the media and maintains the maximal aortic diameter.23 It is com¬ 
posed of loose connective tissue consisting of fibroblasts, elastic fibers and collagen. Unlike the media, the 
adventitial elastic fibers are not organized into lamellae. Collagen in the adventitia limits the maximal ex¬ 
pansion of the vessel and thereby determines its bursting strength.24 25 White et al. postulated that aneurysm 
formation may depend on a loss of elastin’s ability to return the aorta to a normal diameter, whereas aneu¬ 
rysm growth may depend on the balance between degradation and deposition of collagen.26 
Classification of Thoracic Aortic Disease 
Thoracic aortic disease consists of a number of different disease processes, all of which may lead 
to rupture and catastrophic hemorrhage. These processes include aneurysms, dissections, penetrating athe¬ 
rosclerotic ulcers (PAU) and intramural hematomas (IMH). Although classified separately, these are all 
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intcr-rclated pathologies, and distinctions between them have 
been made to facilitate descriptions of clinical presentation. 
Aneurysms 
TAA is simply a localized dilatation of the thoracic aorta 
(Figure 4). The natural history and optimal therapy of TAA var¬ 
ies based on the location and extent of the aneurysm. Therefore, 
they arc classified largely on the basis of location (Table 1). 
Ascending aortic aneurysms comprise approximately 50% of 
Figure 4. Computed tomography (CT) of patient 
with a large aortic aneurysm. (A concomitant 
dissection is visible in the left posterior portion of 
the aorta). 
TAA, aortic arch aneurysms 10%, and descending and thoraco¬ 
abdominal the remaining 40%.29 
Dissection 
Aortic dissection occurs when a tear in the aortic intima 
and inner layer of the media allows blood to course freely along 
a false lumen in the outer third of the media. The result is a dis¬ 
section flap that traverses the aortic lumen, dividing the aorta 
into true and false lumina (Figure 5 and Figure 6). The misno- 
Table 1. Classification of thoracic aortic aneurysm* 
Ascending aortic annulus of aortic valve to origin 
of the innominate artery 
Trans\’erse aortic arch- origin of innominate artery 
to left subclavian artery 
Descending aortic: lowest margin of left subclavian 
artery to aortic diaphragmatic hiatus 
Thoracoabdominal (Crawford's classification)” 
Type I proximal descending aorta to upper 
abdominal aorta 
Type II proximal descending aorta to below 
the origin of the renal arteries 
Type III Distal half of descending aorta ex¬ 
tending into the abdomen 
Type IV Most of/the entire abdominal aorta 
* Adapted from a table by Pitt and Bonser.” 
mer dissecting aortic aneurysm has been used to describe this process. But in the acute setting, dilatation 
of the aorta does not occur. Rather, if the patient survives the acute event, gradual dilatation of the false 
lumen will result.1" Therefore, we prefer the term aortic dissection to indicate the splitting of the media by 
Figure 5. A. The three layered aortic wall, the intima (red) lines the lumen, the ad¬ 
ventitia (yellow) forms the external layer, and the media (pink) sits between. B A tear 
through the intima allows a column of blood to split the layers of the media This 
leads to the intimal flap crossing the lumen, and dividing it into the true lumen (upper 
left) and false lumen (lower right) 
Figure 6. Computerized tomography (CT) of a patient with a 
classic type B aortic dissection Note the intimal flap and 
presence of both true and false lumina. 
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circulating blood, and the term 
aortic aneurysm to indicate a dila¬ 
tation of the aorta. 
Clinically, dissections 
identified within 2 weeks of the 
onset of symptoms are classified as 
acute', subsequently they arc termed 
chronic. There are two classifica¬ 
tion systems which indicate the 
extent of the dissection in the aorta. 
The simplified DcBakey classifica¬ 
tion consists of three types, while 
the simpler — and more commonly 
used —Stanford classification rec¬ 
ognizes two. (Figure 7) 
Penetrating Ulcer 
In PAU, atheromatous 
Figure 7. The classification of aortic dissection. The top row shows the Stanford classification, the 
bottom the simplified DeBakey classification Stanford type A includes any dissection with involve¬ 
ment of the aorta proximal to the left subclavian artery, (this includes both DeBakey type I, which 
extend the length of the aorta, and DeBakey type II, which are confined to the proximal aorta). Stan¬ 
ford type B and DeBakey type III are equivalent categories comprising dissections limited to the aorta 
distal to the left subclavian artery Included with the Stanford classification is the incidence of intimal 
tears in each region of the aorta based on autopsy studies. Adapted from a diagram by Ergin and 
Griepp.30 
plaques ulcerate and disrupt the 
internal elastic lamina. The ulcer 
then penetrates through the intima into the 
aortic media.31 ’’(Figure 8). Although this 
may precipitate a localized intramedial dis¬ 
section, in contrast to classical aortic 
dissection, this localized process is limited 
by areas of severe calcification associated 
with the locally advanced atherosclerotic 
disease.3435 The natural history and optimal 
Figure 8. Diagram of PAU. A. An atherosclerotic plaque penetrates through the 
intima into the media. B With time, an intramural hematoma may form, but it will 
be limited in extent by fibrotic and calcified tissue. 
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treatment of PAU is only now beginning to be ex¬ 
plored36 as better imaging teehniques (including 
MRI. Figure 9) allow for non-operative diagnosis. 
Intramural Hematoma 
Whereas classical aortic dissections are 
thought to begin with a tear which allows blood to 
dissect rapidly along a plane in the outer third of an 
intrinsically diseased media, IMH is thought to oc¬ 
cur following rupture of the vasa vasorum in the 
aortic wall.34 This was first described in 1920 by 
Krukenberg as a “dissection without intimal tear.” 
A diagrammatic representation of IMH can be seen 
in Figure 10, and Figure II shows the appearance 
of IMH on transthoracic echocardiogram. The rela¬ 
tionship between IMH, PAU, and classical 
dissection has not been established. They may in 
fact lie on a continuum with dissection, and much 
work remains to clarify their pathophysiology, natu- 
Figure 10. Diagram of IMH Blood in the media 
(possibly secondary to a rupture of the vasa 
vasorum leads to a concentric hematoma without 
intimal tear 
Introduction 
Figure 9. A MR image (sagittal view) of a patient with a penetrating 
atherosclerotic ulcer. The penetrating atherosclerotic ulcer is diagnosed by 
visualization of a distinct ulcer crater in the absence of an intimal Hap or 
false lumen B MR image (axial view) of a patient with a penetrating 
atherosclerotic ulcer 
Figure 11. Transthoracic echocardiogram (TEE) of a patient with an 
intramural hematoma Note the absence of intimal disruption or 
penetrating atherosclerotic ulcer. 
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ral history, and relationship to classical dissection.34 
Familial Aggregation 
Because this paper examines familial aggregation as a risk factor for complications in thoracic 
aortic disease, and no standardized terminology exists for the various types of aggregation described in the 
literature, it is important to define the use of some terms. Patients with the diagnosis of MFS, MFS-related 
syndromes, or other inherited systemic diseases of the connective tissue are referred to as syndromic pa¬ 
tients. Those patients without such a history, but whose families do illustrate familial aggregation or 
clustering' of disease are termed non-syndromic familial aggregation or non-MFS-related familial aggre¬ 
gation (abbreviated throughout this paper as nMFS familial), because in thoracic aortic disease MFS is the 
predominant inherited syndrome involving a connective tissue defect. Those patients without any evidence 
of familial aggregation are termed sporadic. 
Thoracic Aortic Aneurysms 
History 
Arterial aneurysms have been recognized since at 
the catastrophic implications of aneurysm rupture, noting. 
“if an aneurism be wounded, the blood is spouted out with 
ited with the first description. At the time, he recognized 
least the 2nd century AD, when Galen (Figure 12) is cred- 
the cause or causes of aneurysm have continued unabated; 
so much violence that it can scarcely be arrested.”37 The 
great anatomist Vesalius is credited with the first correct 
clinical diagnosis, in 1557,37 Since then, speculation as to 
unfortunately, almost 450 years later, they remain—to a 
large extent—unclear. 
Figure 12. Early depiction of Gaien. Courtesy Cushing/Whitney 
Medical Library at Yale University, Historical Library. 
’ Different studies will define familial aggregation differently, for example, they may include families with a history of sudden death, 
but without confirmed aortic disease, or they may include any family member or restrict it to first-degree family members. Our defi¬ 
nition will be explained below in the Methods section. The definition used in other studies will be noted where appropriate. 
6 

Davies et al — The Natural History of Thoracic Aortic Disease Introduction 
Much of what we do know about thoracic aortic aneurysms (TAA) has been extrapolated from 
studies of abdominal aortic aneurysms (AAA); less scientific evidence is available on TAA. While the 
known risk factors described in the abdominal aorta are probably important in the thorax, differences be¬ 
tween AAA and TAA necessitate a complete understanding of TAA independent of abdominal disease. 
Etiology 
Normal vessel wall biology involves a balance between the distending forces placed on the aorta 
by the flow of blood under pressure and the ability of the aorta (through the structural integrity of the aortic 
wall) to resist dilatation and elastically rebound when the pressure pulse of each cardiac systole has passed. 
Therefore, factors which either (1) decrease the ability of the aorta to resist distention or, (2) increase the 
distending forces would be expected to result in aneurysmal dilatation. In aortas weakened by processes 
such as genetic defects, atherosclerosis or inflammation,38"10 normal aging,41,42 prolonged hypertension,35 or 
cigarette smoking,43"17 factors increasing the load on the aorta may increase the risk of aneurysmal dilata¬ 
tion. These factors include hypertension,48'52 the process of dilatation itself, and the location of the 
weakening along the course of the aorta. Thus, the etiology of aortic disease involves a complex interplay 
between a variety of factors contributing to weakness of the arterial wall and increased aortic wall pres¬ 
sure.53 
Natural History 
Epidemiology: Incidence and Prevalence 
Because aortic aneurysms are a frequently silent disease, precise estimates of incidence and 
prevalence have been difficult to obtain. Changes in the incidence and prevalence due to changing disease 
patterns have further complicated the matter.50,54,55 The most recent evidence suggests that the incidence of 
TAA is approximately 5.9 per 100,000 patient-years.29 This is consistent with published autopsy rates of 
437 per 100,000 in women and 489 per 100,000 in men.56 
Traditionally the incidence has been thought to be higher in men than women;57'59 however, this 
likely reflects the greater number of men seen in a referral population and possibly a higher rate of recog¬ 
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Growth Rates of Thoracic Aortic Aneurysms 
One might expect that the calculation of aortic growth rates is a simple process. Simply take the 
last size measurement (S;), subtract the first size measurement (Sf) and then divide by the time interval (7) 
between them: 




However, that method is highly subject to measurement error, especially when the time between 
studies is short. In order to account for measurement error, some groups truncate negative growth rates to 
zero; others exclude them from analysis. These divergent methods may explain some of the variation in 
their results. In studies of descending and thoraco-abdominal aortic aneurysms, growth rates have varied 
from 0.2 cm/yr60 to 0.32 cm/yr61. The variation among growth rates when all sites are measured together is 
even higher: 0.10 cm/yr62 to 0.42 cm/yr63. 
Despite the disparities in the exact rates, some consensus exists as to which factors are associated 
with higher relative rates. Chronic obstructive pulmonary disease (COPD) has been associated with faster 
growth rates in multiple studies.51-60 The reason for this association is not clear. Although one might pos¬ 
tulate that it reflects differences in smoking behavior,61 or genetic differences in susceptibility to connective 
tissue disease leading to both increased risk of COPD and increased aneurysm expansion rates.60 Alterna¬ 
tively, thoracic physiology and mechanics, which undergo significant changes in patients with COPD, may 
influence the expansion rate in these patients. 
Initial aortic size greater than 5 cm has been associated with higher relative growth rates,6164 as has 
the presence of renal failure64. Interestingly, as noted above, a history of hypertension has not been found 
to be associated with either faster growth rates or an increased susceptibility to rupture.61’65 The only ex¬ 
ception to this, the study by Masuda et al.,64 measured diastolic blood pressure rather than examining a 
history of hypertension. This supports the idea that adequate treatment of hypertension mitigates the po¬ 
tentially increased risk associated with a history of such disease; follow-up with serial blood pressure 
measurements is the only way to clarify the relationship. Finally, the presence of chronic dissection has 
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been identified as a predictor of higher growth rates in our previous work;66 however, this has not been 
shown universally.61 
Complications: Rupture and Dissection 
The main complications associated with aneurysms are rupture and dissection, either of which 
may result in subsequent death. As noted above the silent nature of TAA has made epidemiological char¬ 
acterization of the disease difficult. In addition, the high mortality rates and the selection of patients for 
surgery lead to several sources of bias in studies of predictors of complications. Few groups have at¬ 
tempted systematic statistical analysis of risk factors for complications in TAA to enable the optimal 
selection of patients for surgical extirpation of their aneurysm. 
Learning from Abdominal Aortic Aneurysms 
Research into the complications of AAA has provided some insights into the behavior of aortic 
aneurysms. However, given the differences between the diseases, extrapolation of those results to TAA 
should be done cautiously, especially since surgery for the thoracic aorta carries significantly different risks 
than surgery of the abdominal aorta. 
Traditionally, size has been the best predictor of AAA rupture.67,68 Szilagyi showed that the natu¬ 
ral (unoperated) history of AAAs > 6 cm had 5 year survival of only 6%, compared with survival of 48% in 
those with smaller aneurysms.69 Hypertension and COPD are independently predictive of higher rupture 
rates.68,70 71 Because the incidence of COPD is so intertwined with the prevalence of tobacco use, it has 
been difficult to separate the influence of the two factors.72 But, in studies which have examined both to¬ 
bacco use and COPD, COPD has consistently been the stronger predictor.68 71 
The impact of higher expansion rates on rupture risk has similarly been difficult to separate from 
the related increase in absolute aortic diameter. Some studies have found both to be predictive, while oth¬ 
ers have not.68 Dr. Cronenwett succinctly summarizes the difficulty in obtaining a full understanding of the 
natural history of aortic disease: “It would require ... a large series of patients with comparably sized 
AAAs but different expansion rates .followed without intervention, to determine whether expansion rate per 
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Thoracic Aortic Aneurysms 
Until recently, most of our knowledge of the natural behavior of TAA (outside of what we have 
learned from analysis of AAA) was derived from a small number of observational studies, and some popu¬ 
lation studies. The first systematic investigation of TAA was done by Boyd in 1924 ” While this study 
described the consequences of rupture, it made no effort to examine risk factors for rupture. Population 
studies have revealed an incidence of ruptured TAA of approximately 5 per 100,000 population.74 Cumula¬ 
tive risks for patients with TAA are substantial: Bickerstaff, et al.29 reported a cumulative rupture rate of 
51% for aneurysms without dissection. Mortality following rupture was a devastating 94%. Subsequent 
work by Kampmeier suggested that arch aneurysms have a worse prognosis,75 but no other attempt to de¬ 
lineate groups at increased risk was attempted. While many of these studies followed large populations, 
they did not attempt to use detailed statistical analyses to understand predictive factors for rupture and 
thereby establish criteria for surgical intervention. 
More recently, Presslcr and McNamara followed a group of 260 patients and looked at the timing 
of rupture.57 Late rupture (more than three days following diagnosis or onset of symptoms) accounts for 
91% of TAA rupture, and 68% of TAA ruptures occurred more than one month after diagnosis.57 Rupture 
accounted for 44% of deaths in their series.57 However, none of these studies addressed the important 
question of which patients were at highest risk for early rupture. 
Previous work in our group showed that high initial aortic size was highly predictive of rupture 
and dissection.66 In the ascending 
aorta, the odds of incurring rupture 
or dissection with aneurysms of 6.0 
to 6.9 cm was 4.27 times that for 
aneurysms of 4.0 to 4.9 cm. In de¬ 
scending aortas, a similar 
phenomenon occurred for the 7.0 to 
7.9 cm range (indicating their lower 
propensity for rupture). We identi¬ 
fied dramatic hinge points in the Figure 13. Estimated effect of aneurysm size on risk of complication (rupture or dissection) for 
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incidence of complications at these size ranges (Figure 13). However, separate analyses were not per¬ 
formed to identify other risk factors for either rupture or dissection. Furthermore, this data provided a static 
“snap-shot" of risk and failed to examine the risk of complications over time, so that a patient followed for 
one month who ruptured had the same impact on the analysis as a patient who ruptured following a five- 
year follow-up. 
Equation 2. Gnepp’s formula for prediction of rupture within one year of size measurement 
Probability of rupture within 1 year = 1 -e ^j65) 
where In A = -21.055 + 0.093(age) + 0.841 (pain) + 18.22{COPD) 
+0.643(descending diameter, cm) 
+0.405(ascending diameter, cm) 
The group at Mount Sinai 
led by Dr. Griepp has published de¬ 
tailed analyses of the incidence of 
rupture in patients with descending 
or thoraco-abdominal aneurysms.65 
Using a logistic regression analysis they were able to provide a multivariable equation to enable the predic¬ 
tion of rupture within one-year based on specific patients characteristics (Equation 2) . However, then- 
analysis was limited to aneurysms of the descending aorta, and their work did not analyze the incidence 
over time but instead looked at incidence within a set time period. 
Intuitively, one would expect that hypertension would increase the risk of rupture and dissection, 
but that has not been demonstrated in any studies.65,66 This may be due to the fact that patients with identi¬ 
fied aneurysms tend to be treated medically with (3-blockade, thereby minimizing the effect of a history of 
hypertension.65 This possibility is supported by the fact that although hypertension predicts higher initial 
aortic sizes,61 it does not predict higher growth rates in most series.61,66 (A study by Masuda, et al76 is one 
exception). Juvonen and associates identified chronic obstructive pulmonary disease (COPD) as the risk 
factor most predictive of rupture.65 This is consistent with studies of AAA as described above. 
Growth rates measurements have been highly variable (see Growth Rates on page 8). So it is not 
surprising that examination of growth rates as a risk factor for rupture has been inconsistent. Some studies 
have correlated higher growth rates with rupture,61 but others have not been able to demonstrate a similar 
association.60 
It is important to note that complications other than rupture or dissection may occur in these pa¬ 
tients. These less catastrophic complications include aortic regurgitation which may occur in ascending 
it 

Davies et al. — The Natural History of Thoracic Aortic Disease Introduction 
aneurysms,77 hoarseness due to compression of the recurrent laryngeal nerve by aortic arch aneurysms, and 
dysphagia or dyspnea due to pressure on the esophagus or trachea.73'75 
Mortality 
Despite their rarity, aortic aneurysms (both AAA and TAA) are the 13th most common cause of 
death in the United States, and their prevalence appears to be increasing ,78'79 Overall 5-year survival in 
patients with TAA is only 56%.80 In 1964, Joyce, et al. demonstrated that patients with aneurysms less than 
6.0 cm in diameter had a 5-year survival rate of 61%, while those with aneurysms larger than 6.0 cm had a 
5-year survival rate of only 38%.59 Since then, little work has further delineated nsk factors predictive of 
mortality in this population, and no further examination of the predictive power of aortic size on mortality 
has been done (probably because of the large sample sizes and detailed follow-up required). Mortality in 
these patients may be attributed to both dissection and rupture.81'83 
Our previous work has shown that survival is significantly worse in patients with descending or 
thoraco-abdominal aortic aneurysms (39% at 5 years) than in aneurysms of the ascending aorta or aortic 
arch (77%,p ^.(Bl).66 In addition patients with a concomitant dissection have poor long-term prognosis 
independent of aneurysm location (46% at 5 years).84 Symptomatic aneurysms also have poor prognosis 
when compared to asymptomatic disease (5 year survival 26.9% versus 58.3%).84 
Treatment 
Advances in the surgical treatment of thoracic aortic disease have led to significantly improved 
early and late results in recent years. However, surgical repair of the thoracic aorta still carries significant 
risk. Because aortic aneurysms are often asymptomatic until rupture or dissection, identifying those pa¬ 
tients who are at risk for complications is central to optimal surgical therapy. Operate early on patients at 
low risk and the risk of complications may not justify the risk of surgery, but operate too late and rupture or 
dissection may occur, necessitating an emergent intervention with higher morbidity and mortality. 
Some patients clearly require surgical intervention, including those with Type A dissections, those 
who are symptomatic, and those with rapidly enlarging aortas. However, a substantial portion of patients 
lack these indications for surgery but remain at risk for serious complications. Identifying those patients at 
highest risk remains a significant challenge. 
12 
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Rupture occurs in 32% to 68% of patients not treated surgically, and 1-, 3- , and 5-year survival 
estimates for patients not undergoing surgical repair are approximately 65%, 36%, and 20% respec¬ 
tively.29,57’85 In contrast, mortality from elective repair at experienced centers may be as low as 2%, 
although estimates range as high as 9%.66,86 The high mortality rate (up to 21%)66 from emergent proce¬ 
dures reinforces the need to identify patients at risk for rupture and operate sooner and electively. 
For patients not considered good operative candidates, the options for medical therapy are limited. 
Currently, (3-blockade is the mainstay of medical treatment. It is thought to exert beneficial effect through 
a reduction in pulse-pressure, mean pressure, and heart rate.87 Although it has been shown to reduce the 
rate of aortic root dilatation and the development of aortic complications in patients with Marfan syn¬ 
drome,88 its use in non-MFS patients has recently come under significant scrutiny because of its effects on 
vascular wall compliance. 
The Inheritance of Thoracic Aortic Disease 
Marfan Syndrome and Inherited Connective Tissue Disease 
Systemic disorders of connective tissue proteins, such as Marfan syndrome (MFS) and Ehlers- 
Danlos syndrome type IV (EDS-TV, resulting from defective synthesis of type III collagen), are known 
causes of dominantly inherited aortic disease. In the case of MFS, 99 different mutations in the fibrillin-1 
gene (FBN1) have been identified in patients with MFS and Marfan-related syndromes.89 Patients with 
MFS and related syndromes present with a variety of connective tissue symptoms, including skeletal mani¬ 
festations,90,91 ocular manifestations,90 and cardiovascular manifestations (especially aortic root enlargement 
and Type A dissections).909293 To date, no genotype-phenotype correlation between the physical location 
of the genetic defect and the systemic manifestations of disease has been identified.93 
In MFS, mutations in FBN1 cause abnormalities in the synthesis and extracellular deposition of fi¬ 
brillin. Patients with decreased amounts of deposited fibrillin-1 have more severe cardiac complications 
and undergo aortic surgery at an earlier age.94 The pathogenesis of the mutant FBN1 gene to be of the 
dominant negative type, where the phenotypic expression depends on the presence of the mutant fibrillin-1 
rather than decreased concentration of wild-type protein.95'97 Additionally, the mutant-type protein may 
13 
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disturb aortic wall homeostasis in the adventitial layer.10 Further work must be done to define the precise 
relationship between defective fibrillin synthesis and aortic dilatation. 
Familial Inheritance in Patients without Systemic Connective Tissue Disease 
Familial aggregation of AAA in patients without known hereditary connective tissue disorders, 
was noticed as early as 1977.98 Subsequently, Tilson and colleagues described 50 families in which more 
than one individual had been diagnosed with AAA.99'101 Further work demonstrated that 19% to 33% of 
patients with AAA had a family member who also had clinically diagnosed disease.10‘ l0? 
Familial aggregation of aneurysms and dissections in 
patients with thoracic aortic disease was noted as early as 
1967,105 but further case studies were not added until after the 
increased interest in familial AAA (Figure 14).104 '06 Biddinger 
et al. went further and in a case-control study, examined the 
prevalence of thoracic aortic disease (TAA, aortic dissection, 
and sudden death) in probands with disease compared to the 
families of their healthy spouses.107 The relative risk for tho¬ 
racic aortic disease in the families of probands ranged from 1.8 to 10 for sisters and brothers respectively. 
More recently, research groups have begun to examine these patients for molecular and genetic 
defects. Two separate groups have identified patients in whom disease can be attributed to mutations in 
FBN1, the same gene implicated in MFS.108 109 Thus mutations in FBN1 can cause a range of phenotypic 
disease from isolated aortic disease to systemic MFS: again no genotype-phenotype correlation has been 
postulated. Less clear was whether or not other genes might be responsible for non-MFS-related familial 
aggregation; especially since these two reports examined a total of only three probands. 
Impact of Familial Aggregation on Natural History 
The natural history of aneurysms due to MFS and MFS-related disorders reveals poor long-term 
prognosis in these patients. In 1972, mean age at death was 32 years, but by 1993 it was 41 years, and me¬ 
dian expected survival in the living population had increased from 48 to 72 years.' '0J'' However, patients 
with MFS are more likely to have aortic regurgitation in association with ascending aneurysms than pa- 
0T0 
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Figure 14. Pedigree of a family demonstrating aggrega¬ 
tion of thoracic aortic disease identified by Nicod, et al!M 
Circles represent women and squares men. Affected 
members are represented by black circles or squares. 
Possibly affected members are represented by grey circles 
or squares. Diagonal bars indicate deceased members. 
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tients without hypertension.112 Also, despite improved survival, patients with MFS continue to require 
repeat aortic surgery at higher rates (25% versus 0% for non-MFS-related aneurysms).112 
Because of small sample sizes, the natural history of aortic disease in patients with nMFS familial 
disease as compared to sporadic cases has not been adequately assessed. Biddinger et al. have performed 
the only analysis for thoracic aortic disease. They noted that there was no statistically significant difference 
in the incidence of hypertension in the probands versus their spouses/controls; however, the controls were 
unaffected individuals, not individuals with sporadic aortic disease.107 More substantial work has been 
done examining the impact of family history on the course of disease in AAA.101113114 Darling et al., found 
that patients with familial AAA and a female family member with an aneurysm had an increased risk of 
rupture (63% versus 37%,p < 0.05).113 They used the term black widow syndrome to describe this in¬ 
creased risk. On the other hand, there was no difference between the patients with sporadic and familial 
AAA in terms of anatomic extent of disease, multiplicity of aneurysms, or associated occlusive disease. 
15 
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STATEMENT OF PURPOSE 
Thoracic aortic disease consists of four entities: aneurysm, dissection, PAU and IMH, all of which 
have high mortality and morbidity rates. On the other hand, surgical repair of the aorta, particularly regions 
with branch vessels to the brain or spinal cord is difficult, and it carries substantial risk of paraplegia, stroke 
and death. Therefore, in order to provide realistic prognostic information, guide the timing of surgery, and 
ultimately improve the outcome in these patients, detailed knowledge of the risk factors associated with 
poor outcomes—both with and without surgery —is required. 
Heretofore, anecdotal evidence has been the mainstay of literature on diseases of the thoracic 
aorta. Thus, despite detailed knowledge of the histopathology associated with aneurysm and dissection, the 
etiologic events leading to aneurysmal dilatation in some people and dissection in others despite pathologic 
findings similar to healthy controls remain unknown. Instead, successive authors have postulated different 
theories which have been difficult to substantiate experimentally and unhelpful in establishing high-risk 
groups for complications (outside of the comparative risk associated with type A versus type B dissec¬ 
tions). 
Despite an extensive literature examining autopsy findings, describing techniques for surgical re¬ 
pair and reporting post-operative outcomes, little literature has focused on the question of which patients 
merit surgery and when. Small sample sizes and early selection for surgery have mitigated the statistical 
power of most series. Our group has published a frequently cited report66 examining size as a risk factor 
for complications, but even this paper examining 230 patients lacked the statistical power to look at com¬ 
plication risk over time. Some risk factors, including the impact of a family history, were also ignored. 
The group led by Dr. Griepp at Mount Sinai have published the only prospective examination of rupture,65 
but it was limited to patients with descending and thoraco-abdominal aneurysm, and did not address those 
patients with ascending or arch aneurysms. 
Given the apparent differences between the behavior of aortic disease in patients with MFS and in 
those without syndromic family history,66 non-syndromic patients with a family history may also be at 
higher risk for rupture. Although family history of AAA has been extensively examined, little is known 
about non-syndromic family history in TAA, and its impact on outcome has not been assessed. 
16 
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Therefore, much remains unclear about the etiology and optimal treatment of patients with tho¬ 
racic aortic disease. Much must be learned if we are to provide effective timing of surgical therapy in these 
patients. In this paper, we examine nearly 700 patients with thoracic aortic disease seen at the Yale Center 
for Thoracic Aortic Disease between October 1985 and December 2000. This analysis aims to define spe¬ 
cific yearly predicted rates of complications and death in this population and sub-populations composed of 
patients with a variety of risk factors in order to develop simple, scientifically-based prognostic indicators 
and surgical intervention criteria for patients with TAA and dissection. 
17 
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METHODS 
Patients and Data Collection 
The patient population we analyzed consisted of all patients seen at the Yale Center for Thoracic 
Aortic Disease during the period October 1985 to December 2000. This population was initially collected 
in 1996 through retrospective analysis of hospital records as described in our previous publication.66 Later, 
patients were added by the author to the retrospectively-collected population through the prospective addi¬ 
tion of patients to a computerized database. 
Initial Recruitment of Study Population 
Patients were initially enrolled in the study by Dr. Michael Coady, Dr. John Rizzo and Dr. John 
Elefteriades after a computerized search had been conducted by Dr. Coady of all patients undergoing mag¬ 
netic resonance imaging, computed tomographic scanning, or echocardiography of the thoracic aorta at 
Yale-New Haven Hospital from October 1985 to March 1996. The search was formatted to exclude pa¬ 
tients who had normal aortic diameters (defined as patients with ascending or descending thoracic aortas of 
less than 3.5 cm in diameter) and no evidence of dissection, PAU or IMH. A search was also conducted to 
identify patients undergoing aortic operations, and autopsy records were examined for all patients who 
died of aortic disease during this time period. This initial recruitment phase identified 230 patients with 
thoracic aortic aneurysm. 
Prospective Recruitment of Study Population 
Subsequent to the collection of the initial population described above and the publication of some 
initial reports with this smaller sample size, the decision was made to begin the prospective addition of pa¬ 
tients seen at the Yale Center for Thoracic Aortic Disease to the database. All patients diagnosed with 
aortic disease seen at the Yale Center between April 1996 and December 2000 were included. At the time 
of initial surgical consultation, datasheets were filled out by the consulting physician. Data collected at that 
time included a history of symptomatic or asymptomatic aortic disease, past medical history including de¬ 
tailed information about specific risk factors for vascular disease, past surgical history, and previous 
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imaging studies. In total, 438 patients with aneurysm (182 with concomitant dissection) and 72 patients 
with dissection alone were collected prospectively. 
All Patients 
In total 668 patients have been identified and compiled into the database (414 with TAA in the ab¬ 
sence of dissection and 254 with dissection—of these, 26 patients with PAU were identified and 23 were 
identified with IMH). 
A hospital chart review was then conducted on identified patients (chart review on the initial 
group of patients was performed primarily by the authors of the initial paper,66 although additional data on 
all patients was collected subsequent to the author joining the project by a variety of researchers including 
the author. Dr. Michael Coady, Dr. Lee Goldstein, and others). Specifically, the author (Mr. Davies) per¬ 
formed data collection on 314 patients. Data recovered from hospital records and computer files were 
cross-checked by Dr. Rizzo with hospital discharge abstract data monitored by the Connecticut Hospital 
Association and Connecticut State Mortality Records. Risk factors for vascular disease were assessed (to¬ 
bacco use, diabetes mellitus, hypertension, lipid profile, cardiac disease and renal dysfunction), as were a 
variety of other risk factors for morbidity and mortality (pulmonary disease, cancer). Where possible, risk 
factors were graded as mild, moderate, or severe according to the suggested standards for reports pertaining 
to lower extremity ischemia as formulated by the Ad Hoc Committee on Reporting Standards of the Soci¬ 
ety of Vascular Surgery and the International Society of Cardiovascular Surgery of North America.115 
Where severity could not be established, we conservatively graded the disease as mild. 
In defining the type and extent of aneurysmal disease at presentation, presentation with aortic dis¬ 
ease was considered to occur at the first presentation to any medical professional with the symptoms of 
thoracic aortic disease (or in the case of asymptomatic disease, the presentation at which the disease was 
discovered). When a patient’s first presentation occurred outside of Yale-New Haven Hospital, data was 
recovered from other health care providers where possible. Otherwise, the unavailable information was 
coded as such in the database, and those patients were excluded from analyses requiring unavailable infor¬ 
mation. 
Periodic re-review of computerized hospital records—particularly imaging studies—was also per¬ 
formed. This re-review (performed by the author) occurred on a bimonthly basis for a selected group of 
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active charts so that each chart was examined at least once per year. A computerized database was main¬ 
tained initially in Microsoft Excel as part of ongoing studies at the Yale Center for Thoracic Aortic 
Disease, a major referral center for New England. Subsequently, this database was converted to a relational 
database designed by the author in Microsoft Access2000 (©2000, Microsoft, Inc., Redmond, WA) and 
continues to be maintained by the author at the Yale Center. 
The database includes 3115 radiographic studies (985 CT scans, 418 MRI scans, 139 TEE studies, 
1344 TTE studies, and 229 angiographic studies) and 20 intra-operative size measurements performed on 
patients with thoracic aortic disease, all compiled by the author. Dinsmore, et al."6 have reported a high- 
degree of correlation between CT, MRI and echocardiography, so measurements from these modalities 
were combined (they continue to be maintained separately in the database so that with larger sample sizes, 
we may be able to examine the differences between them). Size measurements during aortic angiography 
are less accurate, and often result in significant magnification of the aneurysmal aortic diameter; therefore, 
although angiographic data was used to identify the presence or absence and type of aortic disease in these 
patients, size measurements made at angiography were excluded from analysis. The thoracic aorta was 
considered aneurysmal if it attained a maximal diameter of 3.5 cm or greater. 
During the 15-year period, a total of 397 patients out of the 668 underwent surgical treatment of 
the thoracic aorta. There were 259 elective procedures, and 138 emergency procedures. Operations in¬ 
cluded 283 procedures on the ascending aorta or aortic arch (93 emergent and 190 elective), and 114 
procedures on the descending or thoracoabdominal aorta (45 emergent and 69 elective). Operations on the 
ascending aorta were performed with the use of cardiopulmonary bypass with myocardial preservation by 
systemic hypothermia, topical hypothermia with iced saline solution, and cold crystalloid or blood car¬ 
dioplegia. Deep hypothermia and circulatory arrest were used uniformly for arch replacements and 
liberally for the distal anastomosis of ascending aortic replacements. Since 1987, operations on the de¬ 
scending aorta have been performed routinely with the use of left atrial-femoral artery bypass with a 
centrifugal pump without an oxygenator, except when the patient’s condition was not stable enough for 
cannulation; in this case, the operation was done by the “clamp-and-sew” technique. 
Recent data from our group has identified stroke as a common complication in operations on both 
the ascending and descending operation.117 The majority of strokes resulted from embolic sources; there- 
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fore, since 1999, additional protective techniques have been employed, including: care in the mobilization 
of the descending aorta, debridement of atherosclerotic aortic cuffs, TEE-guided location of cannulation 
and perfusion sites, C02 flooding of the operative field, placement of the proximal clamp prior to the insti¬ 
tution of femoral perfusion in descending operations, and avoidance of cannulating a fibrillating left atrium 
Growth Rates 
Of the 668 patients with thoracic aortic disease, there was a core group of 332 patients who were 
observed with serial imaging studies. Serial imaging consisted of 2 or more size measurements separated 
in time. This group of 332 patients consisted of 190 individuals with aneurysms of the ascending aorta, 24 
of the aortic arch, 40 of the descending aorta, and 78 of the thoraco-abdominal aorta. Dissection was pre¬ 
sent in 129 patients and absent in 203. The period of serial radiological follow-up prior to surgery ranged 
ffom 0 to 171.7 months, with a median of 19.1 months. These patients were followed longitudinally and 
this sample was used to estimate aneurysm growth rates and to identify risk factors affecting aneurysm 
growth in a multivariable model. 
Analysis of Complication Rates in Thoracic Aortic Aneurysms 
Of the 668 patients in the database, 304 patients met the inclusion criteria for the analysis of com¬ 
plication rates. Inclusion criteria were as follows: aortic size s 3.5 cm and age > 6 years at presentation. 
absence of congenital aortic malformations (for example, aortic 
coarctation), absence of chronic dissection at presentation, and at least 
one size measurement prior to operative repair. 
These 304 patients form the basis for the analysis of compli¬ 
cation rates. Patient characteristics are shown in Table 5 on page 29. 
There were 178 males and 126 females. Mean age in this population 
Table 2. Distribution of 92 end-points.* 
Events # patients 
dissection. rupture & death 2 
dissection, rupture (no death) 2 
dissection, death (no rupture) 5 
rupture, death (no dissection) 4 
rupture alone 5 
dissection alone 15 
death alone 44 
* Some patients satisfied multiple end¬ 
points, leading to the total of 92 specific 
events 
was 59.8 years and ranged from 8.8 to 93.7. Available radiologic follow-up in these patients ranged from 0 
to 262 months with a median of 31.6 months. There were 28 patients with Marfan syndrome and no pa¬ 
tients identified with other inherited systemic connective tissue diseases. Among the 92 hard end-points 
(rupture, dissection or death) realized in serial follow-up of these patients, were 55 deaths, 13 documented 
ruptures and 24 new, acute aortic dissections (Table 2). We examined the mortality records of all patients. 
Ten mortalities could be attributed defmitively (based on death certificates and autopsy records) to causes 
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other than aortic aneurysms (for example, metastatic lung cancer or pancreatic cancer). It is likely that 
some of the remaining mortality represented aneurysm rupture and that the true incidence of rupture in this 
population was even higher than in our tabulation. 
In contrast to most studies of the natural history thoracic aortic aneurysms, we did not limit our 
analysis to patients excluded from surgery. Instead, we followed patients from diagnosis until they were 
lost to follow-up or were treated surgically. Although this will lower the cumulative rates of complications 
by including patients who were followed for only a single month, it provides a more accurate picture of risk 
over time, and a more accurate picture of the entire population of patients with thoracic aortic disease. 
Statistical Analysis 
Growth Rate Analysis 
Traditional methods for the estimation of aneurysm growth rates have been prone to measurement 
error.62118,119 Consequently we have used the IV approach to growth rate estimation as described by Rizzo, 
et al.118 "9 Specifically, we used SAS 6.12 (©1996, SAS Institute, Inc., Cary, NC) to calculate growth rate 
estimates and 95% confidence intervals (Cl) for patients and sub-groups with varying risk factors. The 
estimates were obtained by means of multivariable regression analysis in which aneurysm growth followed 
an exponential path. In particular, the natural logarithm of the last measured size and the first measure size 
was related to the time interval between the two tests and interactions between this time variable and risk 
factors. 
The multivariable models for aneurysm growth rates are estimated as follows: 
Equation 3 
r- _ o (aTime+p Time-RISK'+dTime-RISK’) • e 
where Sl = last size measurement, S^ = first size measurement, Time = the duration between the last and 
first size measurement and RISK’ and RISK’ ’ are coefficients indicating the presence or absence of par¬ 
ticular risk factors being analyzed (chronic dissection, hypertension, size, etc...). Taking the natural 
logarithm of each side of Equation 3 yields: 
Equation 4 
In .S', = In S f + a ■ Time + /3 ■ Time■ RISK'+0-Time- RISK’ 
Subtracting loSyfrom both sides of Equation 4 we get: 
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Equation 5 
In = a • Time + (5 • Time • RISK' + 6 • 77rac • RISK" 
Equation 5 is the equation we estimate for the full sample of 332 patients where RISK’ = 1 if a 
dissection is present and 0 if absent. RISK’ ’ was eliminated from the overall estimation but was added for 
the separate regressions described below. This equation is estimated without an intercept term because 
when Time = 0, we must have 5, = Sf. The estimated regression was: 
Equation 6 
= 0.017791 • Time + 0.011298 • Time • RlSK\DISSECTION) 
Separate regressions were estimated for ascending versus descending aneurysms, as well as for the interac¬ 
tion where RISK’ ’ was included as a measure of initial aortic size. 
Growth rates were calculated using the above terms, starting with: 
Equation 7 
Growth = S[ - Sj- 
Combining Equation 3 and Equation 7 yields: 
Equation 8 




Growth = Sjr(e (ccTime+P Time-RISK'+6 Time-RISK") -1) 
Confidence intervals were obtained using the upper and lower estimates of each parameter in the regression 
model. Dr. Rizzo provided consultation in the methods of IV estimation, but all statistical analysis was 
performed by the author. 
Analysis of Complication Rates in Thoracic Aortic Aneurysms 
Statistical methods were used to identify and estimate risk factors for the following outcomes: 
cumulative incidence of major complications, survival free from major complications, and overall long¬ 
term survival. Results are not shown for the analyses with stratified levels because they did not provide 
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any additional information. All analyses were performed by the author with consultative assistance from 
Dr. Rizzo. 
The methods of statistical analysis included: x test f°r comparisons of dichotomous risk factors 
(history of coronary artery disease, congestive heart failure, abdominal aortic aneurysm, etc...) with nega¬ 
tive outcomes (rupture, dissection, death), Mantel-Haenszel X test f°r comparisons taking into 
consideration ranked scores of disease severity (cardiac disease, pulmonary disease, increasing aortic size, 
etc...), the Wilcoxon test for one-way analysis of variance between means for comparisons between two 
groups (for multiple groups, Bonferonni’s test was used). The criteria for statistical significance was p < 
0.05 for all univariate tests. 
Logistic regression analysis of the cumulative incidence was used to generate multivariable mod¬ 
els predicting increased incidence of complications. Life table estimates (Kaplan-Meier) were calculated 
using the LIFETEST procedure of SAS 6.12 for PowerPC (©1996, SAS Institute, Cary, NC) with the log- 
rank test for difference between strata. The Cox regression model (using the PHREG procedure, SAS 
6.12), in a forward stepwise manner, was used to identify the most predictive variables in the analysis of 
survival and complication rates over time. 
Multivariable regression analyses (both logistic regression and Cox proportional hazards regres¬ 
sion) was performed under two models in order to assess: (1) the most conservative estimate of multivariate 
predictors of rupture or dissection and (2) all factors which might (if the sample size were large enough to 
demonstrate statistical significance) influence the incidence of rupture or dissection. Forward selection was 
used for both, with the threshold for entry p < 0.05 for the conservative model and p < 0.70 for the other 
model. Both models are reported, along with statistics describing their accuracy. 
Determination of Family History and Genetic Analysis 
Patient Collection and Data Analysis 
Of the 668 patients described above, 60 patients had a history of Marfan syndrome, 608 patients 
had no history of MFS, MFS-related disease, or any other inherited systemic connective tissue disorder. 
Five patients were excluded from further analysis because their aneurysm was found to be due to congeni¬ 
tal disease of the aorta (eg. post-stenotic dilatation after aortic coarcatation). Of the 603 patients remaining. 
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534 had confirmed TAA (171 with concomitant dissection) and 69 had aortic dissection in the absence of 
TAA. Four interviewers attempted to contact 450 patients; 117 patients were lost to follow-up. Complete 
medical and family histories on 278 patients (60 with MFS, 218 without—142 males and 76 females) were 
obtained. All telephone screening was carried out consistently by the four trained interviewers (including 
the author, who contacted 79 of the 278 patients). Responses were recorded on standardized forms. Pedi¬ 
gree analysis was performed on families in which more than one member had an aortic aneurysm. 
We defined nMFS familial thoracic aortic disease as either aneurysm or dissection occurring in 
patients with 1 or more first-degree relatives with aneurysm or dissection and no history of MFS or other 
inherited systemic connective tissue defect. For the purposes of this study, patients with family members 
known to have AAA or cerebral aneurysms were included in the family history group. This was done, in 
part, because some families with multiple individuals affected by TAA also had family members with AAA 
or cerebral aneurysms, suggesting a possible connection between these forms of aneurysmal disease. We 
defined sporadic cases as those occurring in patients with no family history of aortic disease and no history 
of Marfan syndrome or any other inherited systemic connective tissue defect. Patients with a family history 
of sudden death (although included in other studies of familial risk of aneurysmal disease)107 were not con¬ 
sidered to have a family history and were included with the sporadic cases. Patients with a diagnosis of 
Marfan syndrome met the revised criteria for the diagnosis as outlined by DePaepe, et al.90 
Statistical methods were used to compare the 3 categories of aortic disease: nMFS familial, spo¬ 
radic, and MFS-associated. Separate analysis was carried out for the 3 categories of patients, additionally 
those patients in whom a positive or negative family history was obtained were compared to the 344 pa¬ 
tients for whom family history was not known, in order to assess the impact of the patient collection 
method. All statistical analysis was performed by the author. 
Serial follow-up was available for 41 patients in the familial non-syndromic group, 174 patients in 
the sporadic group, and 47 patients in the MFS group. Mean follow-up time for the 3 categories was 49.6 
months (median 33.3, range 0.0 to 317.7 months) for patients with familial non-syndromic TAA, 43.9 
months (median 31.8, range 0.0 to 224.2 months) for sporadic TAA, and 101.9 months (median 91.3, range 
0.0 to 415.5 months) for patients with MFS. As described above, subsets of patients were used for the 
various analyses. When growth rates were calculated, the exclusion criteria detailed under Growth Rates 
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on page 21 were used. Sample sizes were not sufficient to perform separate complication rate analyses for 
each group: sporadic, familial-nMFS, and MFS-related, nor were they sufficient to use the presence of a 
family history as a risk factor for the analysis of complication rates. 
Genetic Analysis 
Patients identified as having a non-syndromic family history were contacted and blood samples 
were collected after appropriate informed consent was signed. Blood samples were provided to the labo¬ 
ratory of Richard P. Lifton, MD, PhD, in the Department of Genetics and the Howard Hughes Medical 
Institute. Personnel in the laboratory performed the following work: 
Genomic DNA was obtained from whole blood samples by standard procedures.120 Genotyping of 
a total of 6 polymorphic loci spanning a region surrounding FBN1 was performed by PCR with a custom¬ 
ized set of primers in a single collected family. PCR products were labeled by incorporation of fluorescent 
end-labeling of oligonucleotide primers with analysis performed on an ABI 377 instrument equipped with 
GENESCAN 2.1 and GENOTYPER 1.1.1 software (Applied Biosystems). Genotypes were scored by a 
single investigator blinded to infection status. Marker order was obtained from databases at the Whitehead 
Institute for Biomedical Research/MTT Center for Genome Research, The Cooperative Human Linkage 
Center, and The Genome Database, and analysis of linkage was performed by use of the GENEHUNTER 
program121 on a SUN SparcStation. 
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RESULTS 
Characteristics of the Entire 
Study Population 
Demographic characteristics and 
the incidence of risk factors for the entire 
study population are given in Table 3. 
The male:femalc ratio was 1.6:1. Other 
comorbidities—especially vascular co¬ 
morbidities—abounded. In particular, 
347 patients (63.6%) had a history of 
hypertension. There were 30 patients 
Table 3. Demographic characteristics of 668 patients with thoracic aortic disease 
Variable N % Mean Median Range 
Sex (male) 414 
Age at presentation (yrs) 604 
Aortic diameter at presenta- 488 
tion (cm) 
Hypertension (n = 546) 347 
Cardiac Diseasefn = 496) 196 
Pulmonary Disease (n = 512) 98 
Renal Disease (n = 496) 56 
Carotid Disease (n = 472) 61 





Marfan syndrome 60 
62.0 % 
60.4 67.1 7 days to 
95.2 years 











9 .0 % 
(12.0%) with a history of AAA (defined as a previously diagnosed, but not necessarily repaired abdominal 
aortic aneurysm). 
Aneurysm Growth Rates 
Aneurysm growth rates were calculated as described earlier. Table 4 shows the average growth 
rate according to initial aneurysm size and risk factor status. Aneurysms in the descending or thoraco¬ 
abdominal region had substantially 
higher growth rates (0.19 cm/yr) than 
those in the ascending aorta or aortic 
arch (0.07 cm/yr). This information 
is presented graphically in Figure 15. 
A similar difference in growth rates 
was found with dissected (0 14 
cm/yr) versus non-dissected (0.09 
cm/yr) aortas. Patients with Marfan 












3.5- 3.9 4.0 -4.9 5.0 - 5.9 6.0 - 6.9 All 
Initial Aneurysm Size 
syndrome and those with a history of Figu re 15. Multivariable estimates of aneurysm growth rates by initial aortic size and location. 
The blue bar indicates the growth rates of descending and thoraco-abdominal aneurysms, the 
white bar rates for ascending/arch aneurysms. The red line is the average for aneurysms inde¬ 
pendent of location. 
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Table 4. Multivariate estimates of aneurysm growth rates.* 
Annual growth rate (cmjyr) according to initial aneurysm sizef 
Patient Category <4.0 4.0-4.9 5.0-5.9 > 6.0 All 
All (n = 332) 0.14 cm/yr 0.09 cm/yr 0.08 cm/yr 0.16 cm/yr 0.10 cm/yr 
Location of Aneurysm 
(0.04 to 0.23) (0.02 to 0.16) (-0.01 to 0.16) (0.00 to 0.32) (0.08 to 0.13) 
Ascending or arch (n = 214) 0.13 cm/yr 0.07 cm/yr 0.02 cm/yr 0.08 cm/yr 0.07 cm/yr 
(-0.02 to 0.28) (-0.05 to 0.20) (-0.06 to 0.18) (-0.13 to 0.37) (-0.03 to 0.16) 
Descending or thoraco-abdominal (n = 118) 0.24 cm/yr 0.20 cm/yr 0.19 cm/yr 0.32 cm/yr 0.19 cm/yr 
Comorbidities 
(0.10 to 0.37) (0.08 to 0.32) (0.05 to 0.33) (0.09 to 0.55) (0.11 to 0.26) 
Hypertension (n = 186) 0.14 cm/yr 0.09 cm/yr 0.07 cm/yr 0.15 cm/yr 0.09 cm/yr 
(0.0 to 0.30) (-0.04 to 0.21) (-0.08 to 0.22) (-0.08 to 0.40) (0.01 to 0.17) 
Pulmonary Disease (n = 47) 0.20 cm/yr 0.13 cm/yr 0.14 cm/yr 0.18 cm/yr 0.13 cm/yr 
(0.04 to 0.36) (0.0 to 0.27) (-0.03 to 0.31) (-0.06 to 0.43) (0.04 to 0.21) 
History of Coronary Artery Disease (n = 95) 0.13 cm/yr 0.08 cm/yr 0.07 cm/yr 0.11 cm/yr 0.07 cm/yr 
(-0.01 to 0.27) (-0.04 to 0.20) (-0.08 to 0.22) (-0.11 to 0.35) (0.00 to 0,15) 
Marfan Syndrome (n = 42) 0.14 cm/yr 0.11 cm/yr 0.10 cm/yr 0.20 cm/yr 0.13 cm/yr 
(0.01 to 0.29) (-0.01 to 0.24) (-0.04 to 0.25) (-0.02 to 0.44) (0.05 to 0.20) 
AAA (n = 46) 009 cm/yr 0.04 cm/yr 0.01 cm/yr 0.07 cm/yr 0.04 cm/yr 
(-0.06 to 0.24) (-0.09 to 0.18) (-0.15 to 0.17) (-0.16 to 0.32) (-0.05 to 0.13) 
Chronic Dissection 
Present(n = 119) 0.17 cm/yr 0.12 cm/yr 0.12 cm/yr 0.21 cm/yr 0.13 cm/yr 
(0.04 to 0.31) (0.01 to 0.21) (-0.03 to 0.26) (-0.02 to 0.44) (0.05 to 0.20) 
Absent (n = 93) 0.13 cm/yr 0.07 cm/yr 0.06 cm/yr 0.14 cm/yr 0.08 cm/yr 
(0.03 to 0.23) (0.00 to 0.11) (-0.03 to 0.15) (-0.03 to 0.30) (0 .06 to 0.11) 
t Values indicate aortic growth rate based on regression analysis for patients with serial imaging studies. The regression model used to calculate 
each value includes the variables indicated in the row and column headings, as well as the time between studies. 95% confidence intervals are given 
in parentheses. 
pulmonary disease also had higher growth rates. Growth rate differences between ascending and descend¬ 
ing and dissected and non- 
dissected aneurysms per¬ 
sisted when we controlled 
for initial aortic size. Al- 
All Locations 
□ Ascending oArch □ Descending is Thoraco-abdominal 
— 133 
though the differences in 
growth rates were strong 
trends, the sample sizes 
were not large enough to 
assess statistical signifi¬ 
cance. 
3.5 -3 9 4.0 -4.9 5.0 - 5.9 > 6.0 
Initial Aneurysm Size (cm) 
Figure 16. Histogram of initial aortic size and aneurysm location. 
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Analysis of complications 
Demographic and Clinical Characteristics of the Study Population 
Demographic characteristics and the prevalence 
Table 5. Demographic information 
analysis of complications.* 
on 304 patients included m 
of risk factors for the 304 patients included in the analy- Variable Mean Range 
Initial aortic size (cm) 5.0 3.5 to 11.0 
sis of complication rates are given in Table 5. In this Radiologic follow-up (mths) 43.1 0.0 to 262.6 
Age at presentation (yrs) 59.8 8.8 to 93.7 
population, 142 patients (39.1%) had a history of hyper- Variable N % 
Sex (male) 178 58,9 % 
tension. Again, the prevalence of vascular comorbidities Marfan syndrome 
Aneurysm Size 
28 9.2 % 
was particularly high. The distribution of aneurysms by 3.5 to 3.9 cm 33 10.9 % 
4.0 to 4 .9 cm 133 43.8 % 
initial size is shown in Figure 17 and Figure 16. Aneu- 5.0 to 5.9 cm 78 25.7 % 
2 6.0 cm 60 19.7 % 
rysms of the ascending aorta were substantially more Aneurysm Location 
Ascending 219 72.0 % 






for each aneurysm location is shown in Table 6. Aneu- 
Thoracoabdominal 





rysms of the ascending aorta and aortic arch had smaller 
Cardiac Disease (n = 219) 





initial sizes than those in the descending or thoraco- 
Pulmonary Disease (n = 225) 





abdominal region (p = 0.0001) 
Renal Disease (n = 220) 





CHF (n = 304) 34 10.2 % 
CVA (n =304) 25 7.5 % 
AAA (n = 304) 31 9.3 % 
* percentages may not sum to 100 due to rounding. 
AAA = abdominal aortic aneurysm, CAD = coronary artery 
disease, CHF = congestive heart failure, CVA = cerebrovascular 
accident 
140 
Initial aortic size (cm) 
Figure 17. Histogram of initial aortic size in 304 patients. 
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Table 6. Initial aortic size (cm) in 304 patients with thoracic aortic aneurysms. 
Non Marfan syndrome (n = 276) Marfan syndrome (n = 28)* 
Mean Range Mean Range 
Ascending (n = 219) 4.8t 3.5 to 10.5 4.5 3.5 to 7.0 
Arch (n =18) 5.9t 4.0 to 11.0 N/A N/A 
Descending (n = 28) 5.3 3.5 to 7.5 N/A 
Thoraco-Abdominal (n = 39) 5.7f 3.8 to 9.8 8.3 8.3 to 8.3 
Ascending/arch (n = 237) 4.9+ 3 .5 to 11.0 4.5 3.5 to 7.0 
Descending/thoracoabdominal (n = 67) 5.5+ 3.5 to 9.8 8.3 8.3 to 8.3 
ALL PATIENTS (n = 304) 5.If* 4.6* 
* Differences between patients with Marfan syndrome and those without were not statistically significant at p s 0.05 
t p < 0.005 for the comparison of initial aortic size in ascending versus arch or thoracoabdominal, Bonterroni's test 
X p = 0.0001, Wilcoxon test. 
Complication Rates 
Cumulative Incidence 
Figure 18 illustrates the cumulative incidence of rupture and dissection during follow-up stratified 
by initial aortic size. The incidence increases with increasing aortic size (p = 0.0003). Patients with the 
largest aneurysms (a 6.0 cm) had complication rates more than seven times as high as those with the small¬ 
est aneurysms (< 4.0 cm) (21.7% versus 3%). Similar increases were observed for rupture alone (p = 
0.0006) and acute dissection alone (p = NS), as shown in Figure 19 and Figure 20. 
150 .------------------------.-.-r 
120 - 
3.5 to 3.9 4.0 to 4.9 5.0 to 5.9 6.0 to 6.9 
Initial aortic size (cm) 
Figure 18. Incidence of acute dissection or rapture as a function of initial aneurysm size. The entire column indicates the total number of patients with 
thoracic aortic aneurysms in each size range The black area indicates the number of patients who incurred an acute dissection or rapture of the aneurysm. 
The line graph and associated percentages indicates the percentage of patients in each category who incurred an acute dissection or rapture of the aneurysm 
and corresponds to the axis on the right. 
t Statistically significant increase in complication rates with increasing initial aortic size,p = 0.003. (Mantel-Haenszel'// test) 
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Figure 19. Incidence of rupture as a function of initial aneurysm size The entire column indicates the total number of patients with thoracic aortic 
aneurysms in each size range. The black area indicates the number of patients who incurred a rupture of the aneurysm. The line graph and associated 
percentages indicates the percentage of patients in each category who incurred a rupture of the aneurysm and corresponds to the axis on the right, 
t Statistically significant increase in complication rates with increasing initial aortic size,p = 0.006. (Mantel-Haenszel x2 test) 
3.5 to 3.9 4.0 to 4.9 5.0 to 5.9 6.0 to 6.9 
Initial aortic size (cm) 
Figure 20. Incidence of acute dissection as a function of initial aneurysm size. The entire column indicates the total number of patients with tho¬ 
racic aortic aneurysms in each size range. The black area indicates the number of patients who incurred an acute dissection of the aneurysm. The 
line graph and associated percentages indicates the percentage of patients in each category who incurred an acute dissection of the aneurysm and cor¬ 
responds to the axis on the right. 
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Table 7. Aneurysm size (cm) at the time of complication. 
All Patients Non Marfan syndrome (n = 28) Marfan syndrome (n = 5) 
Mean' Median Range Mean' Median Range Mean Median Range 
All ruptures or 
acute dissections 
(n = 33) 
5.7 cm 
(52 to 6.2) 
5.5 4.0 to 9.3 5.8 
(53 to 6.3) 
5.8 4.0 to 9.3 52 cm 
(3.0 to 7.4) 
4.4 42 to 8.3 
All dissections 
(n = 24)t 
4.6 cm 
(5.1 to 6.1) 
5.4 4.0 to 8.0 5.7 
(52 to 62) 
5.7 4.0 to 8.0 42 cm 42 42 to4.2 
All ruptures 
(n = 13)t 
5.9 cm 
(5.0 to 6.9) 
5.8 4.0 to 9.3 5.9 
(4.8 to 7.0) 
5.9 4.0 to 9.3 5.9 cm 
(0.68 to 11.2) 
5.0 4.4 to 8.3 
Ascending /arch 
(n = 22) 
5.7 cm 
(5.0 to 6.3) 
5.2 4.0 to 9.3 5.9 cm 
(52 to 6.8) 
5.8 4.0 to 9.3 4.5 cm 
(3.8 to 5.1) 
4.3 4.2 to 5.0 
Descending/ 
thoracoabdominal 
(n = 11) 
5.9 cm 
(5.0 to 6.7) 
6.0 4.0 to 8.3 5.6 cm 
(4.9 to 6.4) 
5.8 4.0 to 7.2 8.3 cm 8.3 8.3 to 8.3 
*95% Confidence intervals for the mean are given in parentheses 
tThe sum of all acute dissections and all ruptures is more than 33 because some patients incurred both acute dissections and ruptures. 
The mean and median thoracic aortic sizes at the time of rupture or dissection are shown in Table 7. 
Mean size at dissection was 4.6 cm, while the mean size at rupture was 5.9 cm. Sample sizes were not ade¬ 
quate to demonstrate statistical significance, but trends suggest that complications occur at larger aortic 
sizes in the descending and thoracoabdominal aorta versus the ascending aorta, and at smaller sizes in pa¬ 
tients with Marfan syndrome than in those without. 
Univariate analysis of risk factors predictive of rupture and dissection is shown in the top of 
Table 8. Initial aortic size a 6.0 cm was associated with a nearly four-fold increase in the incidence of 
rupture. Other significant univariate predictors of rupture included location of the aneurysm in the de¬ 
scending or thoraco-abdominal aorta and a history of abdominal aortic aneurysm. In addition, male gender 
conferred significant protection from rupture. The bottom of Table 9 shows risk factors for dissection. A 
history of coronary artery disease was the only statistically significant univariate predictor of dissection. 
The incidence of rupture and dissection was analyzed together at the top of Table 9. Size was a 
powerful predictor of these complications. The protective effect of male gender was consistent, as was the 
increased risk associated with the presence of other vascular diseases including coronary artery disease, 
abdominal aortic aneurysm, or a history of stroke. The bottom of Table 9 also indicates that nearly all co¬ 
morbidities, but particularly vascular diseases, were associated with an increased incidence of death prior to 
surgical correction in this population. Increasing aortic size showed a trend toward increased preoperative 
mortality with an odds ratio of 1.911. 
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Table 8. Univariate analysis of risk factors predictive of rupture or dissection. 
Risk Factor Complication Rate Odds Ratio Odds Ratio 
(with 95% CD 
P value 
Risk Factors for Rupture 
3.5 to 3.9 cm 0/33 (0.0%) 
i 
i 0.198 
Initial Aortic Size 5.0 to 5.9 cm 4/78(5.1%) 1.303 
i I m 1 0.666 
i i ■ 1 






1 ■ "1 
0.044f 
Gender (male) 6/96 (3.1%) 0.365f ' 1 
i 
L ■ 1 0.071 
Marfan syndrome 4/35 (11.4%) 2.839 
i 
r ■ 1 
Aneurysm location (desc/TA) 6/66 (9.1%) 3.243f 

















1 " 1 
1 0.623 
0.085 





















Renal Disease 2/35 (5.7%) i 1 ■ 1 
CAD 7/82 (8.5%) 2.259 
L. m | 0.102 
i r ■ i 







Prior CVA 3/25 (12.0%) 2.873 
i 
r 
AAA 5/31 (16.1%) 4.663f 





i | o nnif 





3.5 to 3.9 cm g I 0.272 i/jJ /o) 
6/78 (7.7%) 0.963 
i 
i 1 1! 
1 
| Initial Aortic Size 5.0 to 5 9 cm 0.939 
i I 1 I 
> 6.0 cm 8/60(13.3%) 
i 
L ■ 1 0.081 i 
i 
r ■ l 
Gender (male) 13/196 (6.6%) 0.542 
i 
i 1 m | 
i 1 ■ i 
Marfan syndrome 2/35 (5.7%) 0.611 
| | 
0.510 1 i 
Aneurysm location (desc/TA) 6/66 (9.1%) 1.200 
1 0.711 
i 1 ■ i 
Hypertension 18/162 (11.1%) 1.936 
i 




■ 1 13/104(12.5%) 1.418 Caidiac Disease 
i 
1 ■ i 
Tobacco History 10/91 (11.0%) 1.073 









1 " 1 
| 2/28 (7.1%) Cdiotiu Disease , i I 
Renal Disease 3/35 (8.6%) 0.810 
i 1 ■ | 
j 1 ■ I 
CAD 7/82 (8.5%) 2.370t 0.028+ 
i 
i L _ 
1 " 1 





■ 3/25 (12.0%) i 1 ■ l 
AAA 4/31 (12.9%) 1.647 1 . 0.381 
i 1 ■ i 
Odds Ratio 0.1 1.0 10.0 
Increasing Risk of Rupture or Dissection -► 
t = Statistically significant results. Bars on graph indicate 95% confidence intervals, odds ratios cannot be calculated when the incidence of the 
measured outcome is zero. AAA = abdominal aortic aneurysm, CAD = coronary artery disease, CHF = congestive heart failure, CVA = cerebrovascular 
accident or stroke, desc = descending, TA = thoraco-abdominal. 
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Table 9. Univariate analysis of risk factors predictive of rupture or dissection and death. 
Risk Factor Complication Rate Odds Ratio Odds Ratio 
(with 95% Cl) 
P value 
Risk Factors for Rupture or Dissection 
3.5 to 3.9 cm 1/33 (3.0%) 0.233 
Initial Aortic Size 5.0 to 5.9 cm 8/78 (10.3%) 0.919 
6.0 cm 13/60 (21.7%) 3.098 
Gender (male) 17/196(8.7%) 0.475 
Marfan syndrome 6/35 (17.1%) 1.613 
Aneurysm location (desc/TA) 11/66(16.7%) 1.927 
Hypertension 25/162 (15.4%) 1.626 
Cardiac Disease 17/104(16.3%) 1.265 
Tobacco History 13/91 (14.3%) 0.957 
Pulmonary Disease 6/51 (11.8%) 0.764 
Carotid Disease 4/28(14.3%) 0.983 
Renal Disease 4/35 (11.4%) 0.753 
CAD 16/82(19.5%) 2.303 
CHF 2/34(5.9%) 0.431 
Prior CVA 6/25 (24.0%) 2.554 

















Risk Factors for Mortality 
3.5 to 3.9 cm 3/33 (9.1%) 0.421 ; h 
-■— 
H a 0.155 
Initial Aortic Size 5.0 to 5.9 cm 11/78 (14.1%) 0.679 i 













Gender (male) 24/196(12.2%) 0.367 
1 
1 




Marfan syndrome 2/35 (5.7%) 0.241 1- —■- -1 
1 
1 0.039f 









1 0.04 If 
Cardiac Disease 24/104 (23.1%) 2.206 1 1-■-1 1 0.02 It 
Tobacco History 18/91 (19.8%) 1.491 
l 
1 H —■——1 1 1 0.252 





Carotid Disease 10/28 (35.7%) 3.278 l 
1 1-■— H ; 0.005f 
Renal Disease 12/35 (34.3%) 3.165 
1 
1 1-*— h : 0.003t 
CAD 17/82 (20.7%) 1.203 
l 
1 1— -*—I 
0 
i 0.561 
CHF 12/34(35.3%) 2.727 1 
l 1-■- i 0.008f 
Prior CVA 9/25 (36.0%) 2.717 
1 
1 1--  i : 0.020t 





: 0.01 It 
Odds Ratio 0.1 1.0 10.0 
Increasing Risk of Rupture, Dissection, or Death -► 
t = Statistically significant results. Bars on graph indicate 95% confidence intervals, odds ratios cannot be calculated when the incidence of the measured 
outcome is zero. AAA = abdominal aortic aneurysm, CAD = coronary artery disease, CHF = congestive heart failure, CVA = cerebrovascular accident or 
stroke, desc = descending, TA = thoraco-abdominal. 
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The results of a 
multivariable regression 
analysis examining risk 
factors predictive of rupture 
or dissection prior to surgi¬ 
cal correction are given in 
Table 10. The only risk 
factor remaining in the 
model following stringent 
selection criteria (p s 0.05) 
was aneurysm size a 6.0 
cm. At that size, the risk of 
incurring a rupture or dis- 







p < 0J0S* 
p Value Odds Ratio f 
Intercept term -22261 0.2476 0.0001 
Aortic Size 2 6.0 cm} 1.0557} 0.4234 0.0126} 2.874} (1253 - 6589) 
Regression Analysis Liberal Model Entry at p < 0.7** 
Variable Parameter estimate Standard error p Value Odds Ratio t 
Intercept term -22261 02476 0.0001 
Aortic Size 
< 4.0 cm -0.9107 1.0884 0.4027 0.402 (0.048-3.396) 
5.0 - 5.9 cm 0.2362 05341 0.6583 1266 (0.445 - 3.607) 
2 6.0 cm} 1.0994} 05127 0.0320} 3.002} (1.099-8.201) 
Age at presentation -0.00757 0.0122 05335 0.992 (0.969-1.016) 
(risk per year) 
AAA 0.4769 05818 0.4123 1.611 (0515 - 5.039) 
CAD 0.7283 0.4548 0.1093 2.071 (0.850-5.051) 
CHF -0.9483 0.7786 02233 0387 (0.084- 1.782) 
§ This variable equals 1 if the patient incurred a rupture or acute dissection and 0 otherwise. 
•Criteria for assessing model fit: -2 Log L: intercept only: 176.919; intercept and covariates: 171.147; for 
covariates: 6.629 with 1 DF (p = 0.001). 
••Criteria for assessing model fit: -2 Log L: intercept only: 176.919; intercept and covariates: 164.400; x2 for 
covariates: 12.826 with 7 DF (p =0.0765). 
t 95% confidence intervals on odds ratios are given in parentheses. 
} Statistically significant at p < 0.05 level. 
section was nearly three 
times as high as for aneurysms of 4.0 to 4.9 cm. When a less stringent selection criteria (p < 0.70) was 
used, the model again demonstrates the importance of vascular comorbidities in predicting rupture or dis¬ 
section in this population. Table 10 indicates that the odds of incurring a rupture or acute dissection are 
2.0 times greater (95% Cl 0.515 to 5.039) for patients with coronary artery disease, and 1.6 times greater 
(95% Cl 0.850 to 5.5051) for those with a history of abdominal aortic aneurysm. 
Incidence of Rupture, Dissection and Death Over Time 
The incidence of rupture or dissection over time as a function of initial aneurysm size is given in 
Figure 21. The rate of ruptures and dissections was significantly higher in patients with higher initial aor¬ 
tic size {p = 0.006). At aortic sizes a 6.0 cm, there is a marked step-up in the average yearly rate of 
complications to 6.9% per year (Figure 22). Proportional hazards regression demonstrates that the hazard 
function is more than 2.7 times worse for patients with size 26.O cm than for those with size between 4.0 to 
4.9 cm, again male sex confers some relative protection from adverse events (Table 11). When less strin¬ 
gent criteria are used to create a proportional hazards model, the importance of size can clearly be seen, in 
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Table 11. Proportional hazards regression of factors predicting increased rates of rupture or dissection, (dependent variables)§ 
Regression Analysis Conservative Model Entry at p < 0.05* 
Variable Parameter estimate Standard error p Value Odds Ratiof 
Size 2 6.0 cmt 1.0023 36f 0.38378 0.0090f 2.725f (1.284 - 5.781) 
Gender (male)t -0.904492ft 0.39089 0.0207ft 0.405ft (0.188 -0.871) 
Regression Analysis Liberal Model Entry at p < 0.70** 
Variable Parameter estimate Standard error p Value Odds Ratiof 
Initial Aortic Size 
3.5 - 3.9 cm -0.429173 1.06710 0.6875 0651 (0.080- 5.271) 
5.0 - 5.9 cm 0.815989 0.51781 0.1151 2.261 0.820 - 6.239 
2 6.0 cmt 1.489282+ 0.49997 0.0029f 4.434f (1.664- 11.813) 
Location (Desc/TA) -0.202180 0.44746 0.6514 0.817 (0.340- 1.964) 
Gender (male)f -1.010436ft 0.41804 0.0156ft 0.364ft (0.160-0.826) 
Pulmonary Disease -0.220534 0.53700 0.3242 0.802 (0.471 - 1.365) 
AAA 0.529420 0.21731 0.5594 1.698 (0.593-4.864) 
HTN -0.126842 0.18055 0.1457 0.881 (0.575- 1.349) 
Cardiac Disease 0.262694 0.27112 0.4160 1.300 (0.913- 1.853) 
§ This variable equals 1 if the patient incurred a rupture or dissection and 0 otherwise. 
♦Criteria for assessing model fit: -2 Log L: without covariates: 274.596; with covariates: 262.811; x* for covariates: 11.785 with 2 DF (p = 
0.0028). 
** Criteria for assessing model fit: -2 Log L: without covariates: 274.596; with covanates: 256.536; y2 for covariates: 18.060 with 9 DF (p 
=0.0345). 
t 95% confidence intervals on odds ratios are given in parentheses, 
f Statistically significant at the 1% level, 
ft Statistically significant at the 5% level. 
Figure 21. Kaplan-Meier cumulative incidence of rupture or dissec- Figure 22. Average yearly rate of rupture or dissection by initial 
tion. Five-year hazard estimates are illustrated for patients as a function aortic size, 
of initial aneurysms size, p = 0.006. 
addition, a history of hypertension or pulmonary disease both show a trend toward increasing rates of rup¬ 
ture or dissection (risk ratios: 1.300 and 1.698,p = 0.14 and 0.32, respectively). 
The importance of size is vividly apparent when rupture is analyzed alone (Figure 23 and Figure 
24). Under the most conservative proportional hazards model the rate of rupture is five times worse with 
aortic size of 5.0 to 5.9 cm and nearly ten times worse with size a 6.0 cm when each is compared with an¬ 
eurysms of size < 4.0 cm (Table 12). Under the less conservative model, size has an even greater impact. 
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Table 12. Proportional hazards regression of factors predicting increased rates of rupture (dependent variables).§ 
Regression Analysis Conservative Model Entry at p < 0.05* 
Variable Parameter estimate Standard error p Value Odds Ratiof 
Initial Aortic Size 
5.0 - 5.9 cm 1.595365 0.86744 0.0659 4,930 (0.901 -26.991) 
2 6.0 cm* 2.256365* 0.81758 0.0058* 9.548* (1.923 - 47.408) 
Regression Analysis Liberal Model Entry at p < 0.70** 
Variable Parameter estimate Standard error p Value Odds Ratiof 
Initial Aortic Size 
3.5 - 3.9 cm -13.536449 1554 0.9930 0.000 (N/A) 
5.0 - 5.9 emtt 1,984684ft 0.99127 0.0453ft 7.277ft (1.043 -50.782) 
2 6.0 cm* 2.715466* 0.94503 0.0041* 15.112* (2.371 -96.321) 
Gender (male)f f -1.487251ft 0.72427 00400ft 0.226ft (0.055 -0.935) 
Age at presentation (risk/year) -0.012866 0.01927 0.5044 0.987 (0.951 1.025) 
AAA 0.531282 0.71240 0.4558 1.701 (0.421 -6.873) 
HTN -0.565626 0.42697 0.1853 0.568 (0.246 1.312) 
Cardiac Disease 0.552271 0.29030 0.0571 1.737 (0.983 -3.069) 
§ This variable equals 1 if the patient incurred a rupture andO otherwise. 
* Criteria for assessing model fit: -2 Log L: without covariates: 112.877: with covariates: 103.063; x2 for covariates: 9.814 with 2 DF 
(p = 0.0074). 
** Criteria for assessing model fit: -2 Log L: without covariates: 112.877; with covariates: 93.424; x2 for covariates: 19.453 with 7 
DF (p =0.0069). 
t 95% confidence intervals on odds ratios are given in parentheses. 
*Statically significant at the 1% level, 
ft Statistically significant at the 5% level. 
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Figure 24. Kaplan-Meier cumulative incidence of rupture. Five-year 
hazard estimates are illustrated for patients as a function of initial 
aneurysm size, p = 0.0045. 
Figure 23. Average yearly rate of rupture by initial aortic size. In this graph 
and those on succeeding pages, the colors consistently indicate the same 
size: blue = 3.5 to 3.9 cm, green = 4.0 to 4.9 cm, yellow = 5.0 to 5.9 cm, and 
red = a 6.0 cm 
and other important risk factors predictive of worse outcomes become visible, including a history of ab¬ 
dominal aortic aneurysm and a history of cardiac disease. Male gender again confers a relative protective 
effect (p = 0.04). Similar risk with increased aortic size is seen when dissection is analyzed alone (Figure 
25 and Figure 26). 
As described above, nearly all risk factors were predictive of increased risk of death prior to op¬ 
eration in a univariate analysis (Table 9). Flowever, when analyzing the survival of these patients prior to 
operative repair with proportional hazards, only a history of abdominal aortic aneurysm (risk ratio 2.218, 
95% Cl 0.985 to 4.597) and increasing age at presentation (risk ratio 1.072 per year, 95% Cl 1.038 to 
1.106) were predictive of poor survival (data not shown). Increasing aortic size was associated with de- 
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Figure 25. Kaplan-Meier cumulative incidence of dissection. Five- Figure 26. Average yearly rate of dissection by initial aortic size, 
year hazard estimates are illustrated for patients as a function of initial 
aneurysms size,/? = 0.1878. 
Figure 27. Kaplan-Meier cumulative survival prior to operative re¬ 
pair. Five-year survival estimates are illustrated for patients as a 
function of initial aneurysm size,/? = 0.0671. 
Figure 28. Average yearly rate of death by initial aortic size. 
creasing survival (p = 0.067) (Figure 27). The 
yearly rates demonstrate dramatic increases at 
sizes a 6.0 cm (Figure 28). 
This step-up in the risk is clearly evident 
when rupture, dissection and death prior to surgical 
repair are considered as endpoints together (Figure 
29), with a mean yearly rate twice as high in pa¬ 
tients with size greater than 6 cm than in those 
with smaller aneurysms. Proportional hazards 
regression of this combined end-point confirmed Figure 29. Average yearly rate of rupture, dissection or death 
based on initial aortic size 
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Table 13. Proportional hazards regression of factors predicting increased rates of complications (rupture, dissection or death) 







p < 0.05* 
p Value Odds Ratio f 
Size 2 6.0 emtt 0.589408tt 0.28672 0.0398ft 1.803ft (1.028 - 3.163) 
Age at presentation (risk/year)t 0.0345161 0.00908 0.000 If 1.035f (1.017- 1.054) 
Regression Analysis Liberal Model Entry at p<0.70** 
Variable Parameter estimate Standard error p Value Odds Raliof 
Size 2 6.0 cmft 0.624428ft 0.31478 0.0473tf 1,867ft (1.007 - 3.460) 
Location (Desc/TA) -0.263983 0.31120 0.3963 0.768 (0.417 1.413) 
Gender (male) -0.367578 0.28381 0.1953 0.692 (0.397 - 1.208) 
Age at presentation (risk/year)f 0.0282691 0.00969 0.0035f 1.029f (1.009 1.048) 
AAA 0.555504 0.36834 0.1315 1.743 (0.847 3.587) 
Pulmonary Disease 0.233892 0.33102 0.4798 1.264 (0.660 2.417) 
Cardiac Disease 0.226279 0.28009 0.4192 1.254 (0.724- 2.171) 
§ This variable equals 1 if the patient ruptured, dissected or died prior to surgical correction and 0 otherwise. 
‘Criteria for assessing model fit: -2 Log L: without covariates: 522 .849; with covariates. 496.325; yl for covariates: 26.524 with 
2 DF (p = 0.0001). 
** Criteria for assessing model fit: -2 Log L: without covariates: 522.849; with covariates: 490.231; y2 for covariates: 32 .618 
with 7 DF(p =0.0001). 
t 95% confidence intervals on odds ratios are given in parentheses 
fStatistically significant at the 1% level 
ft Statistically significant at the 5% level. 
the impact of larger aortic size on 
16% 
□ 3.5 to 3.9 cm a 4.0 to 4.9 cm □ 5.0 to 5.9 cm H > 6 0 cm 
poor outcome prior to surgical 
correction (Table 13). Patients 
with aneurysms of the descending 
or thoraco-abdominal aorta were 
less likely to rupture (odds ratio 
0.768,95% Cl 0.417 to 1.413) in 
this model, but otherwise the 











tors of complications as 
Figure 30. Average yearly rates of all negative outcomes by initial aortic size. 
previously described. The yearly 
rates for all endpoints are summarized graphically in Figure 30. 
Long-Term Survival 
Overall long-term survival for all patients, independent of surgical correction, as a function of ini¬ 
tial aortic size is shown in Figure 31. Larger aneurysms arc associated with decreased long-term survival 
[p = 0.0039). Five-year survival in patients with aneurysms a 6.0 cm is only 56%. Overall, for all patients 
in the database, survival was better for the ascending than for the descending aorta (Figure 32), which may 
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reflect the larger size of descending aneurysms at 
presentation (Figure 16 and Table 6) and higher 
growth rates (Table 4). Survival was also better for 
non-dissectcd than for dissected aortas (Figure 33). 
Long-term survival is better in patients treated with 
elective surgery than in those who require emergent 
Figure 31. Kaplan-Meier cumulative survival. Five-year survival 
estimates are illustrated for patients as a function of initial aortic size.p 
= 0.0671 
surgery or those maintained on medical therapy 
(Figure 34). Postoperative survival for patients 
treated emergently remains poor in this population 
when compared to those treated electively (Figure 35). 
Elective surgery restores a flat survival curve indistinguishable from that of the normal population. 
Figure 32. Kaplan-Meier cumulative survival. Five-year survival esti¬ 
mates are illustrated for patients as a function of aneurysm location,p = 
0.0023. 
Figure 33. Kaplan-Meier cumulative survival. Five-year survival esti¬ 
mates are illustrated for patients as a function dissection status,p = 
0.0002. 
Figure 34. Kaplan-Meier cumulative survival. Five-year survival 
estimates are illustrated for patients as a function of the treatment 
received, p =0.002. 
Figure 35. Kaplan-Meier cumulative survival. Five-year post¬ 
operative survival estimates are illustrated for patients as a function of 
the urgency of the surgical procedure,p = 0.0004 
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The Impact of Genetic Factors on Natural History 
Demographic and Clinical Characteristics of the Study Population 
Table 11 indicates the baseline charac¬ 
teristics in the 218 patients without MFS for 
whom we were able to ascertain the presence or 
absence of a family history. These patients are 
compared to the 344 patients in whom we were 
not able to obtain a family history. Overall, the 
two populations are similar in terms of aneunsmal 
disease. However, patients we contacted were 
more likely to have a type B dissection {p - 
0.003) and an aneurysm in the 4.0 to 4.9 cm range 
at presentation (p = 0.037), as well as a history of 
pulmonary disease (p = 0.007) or stroke (p 
=0.035). 
Two hundred thirty-three patients with¬ 
out MFS were interviewed. Of the 233 patients, 
44 (29 men, 15 women) (18.9%) were found to 
have at least 1 first-degree relative with aneuris- 
mal disease, and were considered non-MFS- 
related familial (nMFS familial); the remaining 
cases were considered sporadic. Table 15 sum- 
Table 14. Comparison of demographic characteristics in patients between 
patients with known (+ or -) family history and those with unknown family 
history. (Numbers are percentages unless otherwise indicated) 
Known 
(n = 218) 
Unknown 
(n = 344) p value 
Sex (male) (n = 562) 65.2 59 2 0.137 
Age at presentation (n = 560) 63.7 yrs 64.1 yrs 0.820 
Initial aortic size (n =562) 
Mean (cm) (n = 441) 5.01 cm 5.07 cm 0.644 
< 3.5 cm 233 27.8 0380 
3 3 to 3.9 cm 6.9 10.8 0.104 
4.0 to 4.9 cm 35.6 27.8 0.037t 
5.0 to 5.9 cm 19.3 18.1 0.711 
6.0 to 6.9 cm 6.0 9.2 0.160 
a 7.0 cm 8.6 6.8 0.406 
Aneurysm Location 
Ascending/Arch (n =275) 112 71.8 0.242 
Descending/thoracoabdominal 22.8 28.2 0.242 
(n = 97) 
Dissection (n = 562) 
Any 45.5 353 0.024t 
Type A 23.6 213 0317 
Type B 26.6 163 0.0034 
Number of Aneurysms (n =562)4 
None 9.9 12.4 0.0714 
Single 61.4 65.1 0.0714 
Multiple 28.8 22.4 0.0714 
Comorbidities 
Hypertension (n = 493) 612 69.8 0340 
Cardiac History (n = 449) 39.8 443 0.351 
Carotid History (n = 429) 13.9 14.4 0.894 
Renal History (n = 450) 11.4 13.1 0378 
Tobacco Use (n = 445) 42.4 39.9 0399 
Pulmonary Disease (n = 465) 26.8 16.3 0.006t 
CAD ( n = 603) 253 26.0 0.864 
CVA (n = 603) 5.6 103 0.0354 
AAA (n = 603) 123 123 0.918 
CHF (n = 603) 8 2 11.1 0.242 
t Statistically significant difference between groups (T-test for difference 
between means in analysis of variance). 
4 p value for Mantel-Haenszel yf for increasing frequency of multiple 
aneurysms in patients with known history. 
marizes the demographic and clinical characteristics of these 44 patients with nMFS familial aortic disease 
(two patients P557A, P557B, were determined to be in the same family). Patients with nMFS familial aor¬ 
tic disease had a similar incidence of dissection when compared with sporadic cases (52.3% vs. 43.9%, p = 
0.316), and a similar frequency of aortic disease in the ascending aorta (76.7% vs. 77.3%, p = 0.940). In 
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contrast, the patients with 
MFS had a lower incidence of 
dissection (20.0% p = 0.001) 
and were much more likely to 
have disease in the ascending 
aorta (97.1%,/? = 0.029). 
There was a statisti¬ 
cal trend toward younger 
presentation in patients with 
nMFS familial aortic disease 
than in sporadic cases (58.7 
years vs. 65.0 years), and both 
groups were significantly 
older than patients with MFS 
(26.0 years,/? = 0.0001). Pa¬ 
tients with MFS had a 
significantly lower prevalence 
of nearly all comorbidities as 
shown in Table 16 and de¬ 
picted graphically in Figure 
Table 15. Demographics and clinical characteristics of patients with non-MFS-related familial thoracic 











Size (cm) Site Dissection 
P026 58/M none none mild none 5.4 Asc — 
P030 38/M none none none none 45 Asc — 
P041 76/F none none none mild 3.9 Asc — 
P042 58/M severe severe mild moderate 75 Desc — 
P090 61/F mild none none moderate 3.5 Desc - 
P091 35/M none mild none none — Type A 
P098 35/M none none none none 4.0 Asc — 
P107 80/F moderate mild moderate moderate 12 Asc Type A 
Pill 49/M mild mild none none — 
P141 52/M severe none severe 4.6 Asc — 
P145 24/M none none none none 4.8 Asc Type A 
PI 67 58/F severe moderate none none 9.8 TA — 
PI 84 73/F severe mild mild none 6.0 TA — 
P188 58/M none none mild moderate 4.1 Asc — 
P190 36/M none none none none 4.0 Arch Type A 
P211 47/M none severe none none 3.8 Arch Type B 
P256 65/M 75 Arch 
P265 75/M severe mild moderate none 5.0 Asc — 
P271 74/M severe none none 4.0 — 
P286 64/F severe mild moderate 4.0 — 
P324 79/F none moderate none moderate 6.0 Asc — 
P330 15/F none none none 45 Asc — 
P335 82/F moderate severe none moderate 5.9 Asc Type B 
P345 57/F 
P366 66/M moderate none moderate 4.0 Asc Type B 
P422 48M 4.0 Asc — 
P422 JU none mild none none Type A 
P470 38/M none severe mild 42 Asc Type B 
P511 65/M none none none none Type A 
P518 76/F none moderate none none 55 Asc — 
P546 69/M none mild mild moderate 42 Desc Type B 
P547 75/M mild mild none mild 42 Asc — 
P557A IP 4.1 Asc — 
P557B 59/M none mild none — Type A 
P563 72/F none moderate mild severe 5.0 Asc — 
P565 64/M none mild none none 6.0 TA Type B 
P571 7M 73 Desc — 
P572 60/M mild none none mild — 
P591 81/F none mild none moderate — Type B 
P604 47/F moderate none mild moderate 4.1 Asc — 
P666 60/F none none mild none 53 Asc Type A 
P703 68/M none none mild none 45 Asc — 
P906 86/M mild 6 2 Asc — 
P933 64/M mild moderate severe none 5.0 TA - 
* . indicates that the information was not available for a specific patient (this occurred when presentation 
occurred to an outside hospital and data related to the patient's presentation could not be reliably retrieved 
in a format consistent with that retrieved for patients seen at Yale-New Haven, — indicates that the patient 
did not have a particular type of aortic disease. 
36. In particular, the rates of hypertension and vascular diseases were markedly lower in patients with 
MFS than in the other two groups: no patients with MFS had renal or carotid disease, and only 15.1% had a 
history of hypertension (versus 60.8% of nMFS familial and 68% of sporadic,/? = 0.001). Patients with 
nMFS familial aneurysms did not differ significantly from those with sporadic aortic disease, although 
there was a slight trend toward a reduced incidence of hypertension. Data is not shown for the analysis of 
comorbidities based on the stratified severity scores because no difference was statistically significant. 
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Table 16. Comparison of patients with sporadic, nMFS familial, and MFS-related thoracic aortic disease * 
Variable Sporadic nMFS familial MFS related 
No. of patients (sex) 189 (123 M.66F) 44 (29 M, 15 F) 60 (40 M, 20 F) 
Age (yrs) 65.0 (62.7 to 67.4)f 59.7 (54.8 to 64.7)t 26.0 (21.8 to 30.3)t 
Initial aortic diameter (cm) 5.1 (4.6 to 5.6) 5.1 (4.8 to 5.3) 4.8(4 3 to 5.2) 
Comorbidities 
Hypertension 108 (68.8%)^ 23 (60.5%)t 8 (15.1%)$ 
Cardiac Disease 53 (38.4%)f 15 (45.5%)t 5 (10.6%)t 
Carotid Disease 16 (12.5%)§ 6 (20.0%)§ 0(0.0%)§ 
Renal Disease 17 (12.2%)§ 3 (8.1 %)§ 0 (0.0%)§ 
Pulmonary Disease 58 (43.0%) 15 (40.5%) 11 (23.4%) 
Tobacco Use 35 (24,1%)5 14 (36.8%)3 3 (6.4%)3 
CAD 47 (24.9%)5 12 (27.7%)S 3 (5.0%)5 
AAA 22 (11.6%) 7 (15.9%) 6 (10.0%) 
CVA 10 (5.3%) 3 (6.8%) 1 (1.7%) 
CHF 12 (6.4%)§ 7 (15 9%)§ 3 (5.0%)§ 
Growth rate (cm/yr) 0.08 0.13 0.13 
(-0.02 to 0.18) (0.04 to 0.22) (0.06 to 0.21) 
* Values are given as N (%), or as mean with 95% confidence intervals in parentheses where appropriate. The Bonferonni test for differ¬ 
ences between means was used in the analysis of variance procedure, x2 test was used 10 evaluate difference in prevalence of comorbidities 
between groups. Percentages and N values may not correspond across rows because some patients were excluded from each analysis be¬ 
cause of incomplete information. 
ip <0.0001 
%p< 0.001 
§ p < 0.05 
5 p < 0.005 
100% 
Hypertension Cardiac Carotid Renal Pulmonar^obacco Use CAD AAA CVA CHF 
Disease Disease Disease Disease 
Figure 36. Prevalence of comorbidities analyzed by the presence of a family history. 
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Pedigree Analysis 
Figure 37 displays the family 
pedigrees of a representative group of 26 
out of the 44 patients and their first-order 
relatives. All pedigrees are consistent 
with autosomal dominant transmission 
with reduced penetrance. Some pedi¬ 
grees (for example P286, P546, P271) 
are consistent with autosomal recessive; 
however, the high frequency of affected 
individuals in the affected generation 
(50%) suggests that this simply repre¬ 
sents incomplete penetrance of the 
disease phenotype, rather than a distinct 
mode of inheritance. Some pedigrees 
may also be consistent with X-linked 
inheritance (for example, P141, P167, 
P184). 
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Figure 37. Pedigrees for 26 families with nMFS familial aortic disease. Squares repre¬ 
sent men and circles women. An arrow indicates the proband with thoracic aortic 
disease. Blackened squares or circles represent affected patients with aortic aneurysms. 
Aneurysm Growth Rates 
The initial aortic diameter at the time of diagnosis 
was the same for patients with sporadic disease and those 
with nMFS familial aortic disease (Table 16). Patients with 
MFS tended to have smaller aortic diameter at presentation. 
Aortic aneurysm growth rates for the sporadic, nMFS famil¬ 
ial, and MFS-related TAA are displayed in Table 15 and 
Table 17. Although sample sizes were not sufficient to dem- 
Table 17. Comparison of aortic growth rate according to 
dissection status in patients with sporadic, nMFS familial, 
and MFS-related thoracic aortic aneurysms.* 
Aortic Dissection No Dissection 
Sporadic 0.09 0.06 
(-0.06 to 026) (-0.04 to 0.17) 
nMFS familial 0.16 0.13 
(-0.01 to 034) (0.03 to 0.24) 
MFS related 0.18 0.13 
(0.05 to 0.32) (0.04 to 0.21) 
Overallt 0.13 0.08 
(0.05 to 0.20) (0.06 to 0.11) 
* Values indicate aortic growth rate based on regression 
analysis for patients with and without aortic dissection. 
95% confidence intervals for the mean are given in paren¬ 
theses 
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onstrate statistical significance, patients with nMFS 
familial disease, and those with MFS had higher 
growth rates for both dissected and non-dissected an¬ 
eurysms. Growth rates for dissected aneurysms were 
0.16 cm per year in nMFS familial patients, and 0.18 
cm per year in patients with MFS. Sporadic patients 
with dissection had growth rates of only 0.06 cm per 
year. 
Long-Term Survival 
The survival prior to operative repair was not 
significantly different between patients with a family 
history and those without (p = 0.997, Figure 38). Pre¬ 
dictors of preoperative death were similar in this 
population to the entire population, and the presence 
or absence of a family history did not enter into a pro¬ 
portional hazards model which continued to 
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Figure 38. Kaplan-Meier cumulative survival prior to operative repair. 
Five-year survival estimates are illustrated for patients as a function of 
familial history. (p = 0.997) 
Years 
Figure 39. Kaplan-Meier cumulative survival. Five-year survival 
estimates are illustrated for patients as a function of familial history, ip 
= 0.0902) 
Table 18. Proportional hazards regression of factors predicting decreased long-term survival when familial history is included as a risk factor (dependent 
variables).§  
Regression Analysis Conservative Model Entry at p<0.05* 
Variable Parameter estimate Standard error p Value Risk Ratiof 
Size 2 6.0 cm1 1.2045031 0.46678 0.0099f 3.335f (1.336-8.326) 
Cardiac Disease*’ 1.125778ft 0.46606 0.0157ft 3.083ft (1.237 - 7.685) 
Regression Analysis Liberal Model Entry at p < 0.70" 
Variable Parameter estimate Standard error p Value Risk Ratio f 
Initial Aortic Size 
3.5 - 3.9 cm -14.54718 1715 0.4559 0.000 N/A 
ar 6.0 cm 0,909644 0.47785 0.0570 2.843 (0 973 - 6.336) 
nMFS familial history 0.466472 0.71212 0.5124 1.594 (0.395 6.438) 
Age at presentation (per year) 0.023342 0.01736 0.1789 1.024 (0.989 1.059) 
Location (Desc/TA) 0.566817 0.69088 0.4120 1.763 (0.455 -6.827) 
Pulmonary Disease -0.675778 0.60925 0.2673 0.509 (0.154 - 1.679) 
AAA 0.820452 0.70731 0.2461 2.483 (0.973 - 6.336) 
Cardiac Disease11 1.129986ft 0.57202 0.0482ft 3.096tf (1.009 9.498) 
§ This variable equals 1 if the patient incurred died and 0 otherwise. 
♦Criteria for assessing model fit: -2 Log L: without covariates: 138.583; with covariates: 125.499; y1 for covariates: 13.084 with 2 DF Ip = 0.0014) 
** Criteria for assessing model fit: -2 Log L: without covariates: 138.583; with covariates: 118.030; for covariates: 20.552 with 8 DF ip =0.0084) 
t 95% confidence intervals on odds ratios are given in parentheses, 
t Statistically significant at the 1% level, 
ft Statistically significant at the 5% level. 
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demonstrate similar predictors of decreased survival as noted above (Table 13). 
Long-term survival between groups (independent of operative repair) did not differ significantly in 
a life-table analysis (p = 0.0902XFigure 38), and the conservative proportional hazards model demonstrated 
only that size 2 6.0 cm and a history of cardiac disease predicted poor long-term survival (Table 18). How¬ 
ever, under the less conservative multivariable model (Table 18) there was a trend toward an increased risk 
of death over time in patients with nMFS familial disease (odds ratio 1.594, 95% Cl 00.395 - 6.438). 
Other predictors of earlier mortality in this population included location of the aneurysm in the descending 
or thoraco-abdominal aorta, increasing age at presentation, and a history of cardiac disease. 
However, a serious limitation of long¬ 
term survival analysis in this population becomes 
evident when the survival function of patients 
included in the analysis is compared to survival in 
those in whom we were unable to ascertain a 
family history. Mortality in the group we were 
able to contact (independent of family history 
status) was significantly lower than in the group 
with unknown family history (p = 0.0003) (Figure 40). 
Analysis of linkage was performed on a single family with nMFS familial aortic disease in order 
to assess the potential for linkage in this family to the genetic locus containing the FBN1 gene. Affected 
individuals in this family did not share any alleles at the FBN1 locus, excluding defects in fibrillin as a 
potential cause in this family. 
Figure 40. Kaplan-Meier cumulative survival. Five-year survival esti¬ 
mates are illustrated for patients as a function of whether or not we were 
able to ascertain a family history, {p = 0.0003) 
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DISCUSSION 
Aneurysm Growth Rates 
Growth rates in this population were consistent with previous estimates.4,60'64 The mean aortic 
growth rate was 0.10 cm per year. Sample sizes in the groups analyzed were not sufficient to assess statis¬ 
tical significance; however, some trends can be noted. The largest aneurysms (a 6.0 cm) grew at higher 
rates than smaller aneurysms. Surprisingly, the smallest aneurysms (< 4.0 cm) grew at particularly high 
rates, even when the incidence of concomitant dissection and Marfan disease were accounted for. This 
high rate may reflect the inclusion of aneurysms in the aortic root where the sinuses can dilate rapidly and 
asymmetrically. Because we used maximal aortic diameter, rather than cross-sectional area as our meas¬ 
urement of aortic size, the size and growth rates of these aneurysms may have been over-estimated. 
Consistent with previous reports,4,60,64 aneurysms in the descending or thoraco-abdominal aorta, those with 
concomitant dissection and those in patients with a history of pulmonary disease or with Marfan syndrome 
also tended to grow faster. 
Analysis of Complications 
Examining the natural history of thoracic aortic aneurysms is complicated by a number of issues 
specific to the disease which make scientific assessments of risks difficult. Patients with large aneurysms, 
high rates of growth between imaging studies, and those with significant symptoms are usually selected for 
surgical intervention. Those who were not selected for surgery may have been excluded as operative candi¬ 
dates because of significant comorbidities. Therefore, studies of risk factors for complications require large 
sample sizes. This is the first report from our center in which data is robust enough (1383 years of patient 
follow-up before surgical intervention) to permit statistically valid calculation of yearly rates of rupture or 
other complications for aneurysms of different sizes. 
This study confirms that thoracic aortic aneurysm is intrinsically a lethal disease and that aneu¬ 
rysm size has a profound impact on rupture, dissection and death. In the conservative proportional hazards 
models, size is the only predictor of increased risk of rupture and one of two factors predicting increased 
risk for the compound end-points of rupture or dissection and rupture, dissection or death. 
47 

Davies et al. - The Natural History of Thoracic Aortic Disease Discussion 
We find that the mean rate of rupture or dissection is only 2% per year for small aneurysms, rises 
to 3% for aneurysms 5.0 to 5.9 cm, and jumps to 6.9% for aneurysms greater than 6.0 cm in diameter. The 
risk of rupture alone is near zero for small aneurysms, rises to 1.7% per year for aneurysms 5.0 to 5.9 cm, 
and jumps to 3.6% per year for aneurysms greater than 6.0 cm in diameter. Using a multivariable propor¬ 
tional hazards model, we estimate a 15-fold increase in risk with aortic size £ 6.0 cm versus that for 
aneurysms 4.0 to 4.9 cm. The risk of rupture, dissection or death from all causes is 6.5% at aneurysm size 
5.0 to 5.9 cm and jumps to 14.1% per year for aneurysms greater than 6.0 cm. These data confirm the 
devastating prognosis associated with aneurysms s 6.0 cm which we identified in our previous work.66 
It is anticipated that these size-specific rates may be of use in counseling individual patients pre¬ 
senting for consideration of elective pre-emptive surgical extirpation of asymptomatic aneurysms. These 
data confirm that thoracic aortic aneurysm is a highly lethal condition and support pre-emptive surgical 
correction. It is important to emphasize that this data is for asymptomatic aneurysms and that symptomatic 
aneurysms require extirpation regardless of size. The general thrust of this data suggests intervention be¬ 
fore aneurysm size reaches 6.0 cm, consonant with findings and recommendations from our earlier report 
on a smaller number of patients.66 
For individual patients at specific centers, the center’s surgical risk can be factored into 
the decision-making. At our institution, for experienced operators, hospital mortality is 2.5% for elective 
ascending and arch and 10.9% for elective descending and thoraco-abdominal aortic operations.117 This 
indicates that surgical repair done electively promises lifetime protection at a mortality “cost” comparable 
to, or less than, a single year’s natural rupture or dissection rates. The very flat survival curve (Figure 35) 
following pre-emptive surgical repair approaches that of a normal age and sex matched population and con¬ 
firms vividly that surgical repair protects life long-term. 
Certain limitations of these data can be enumerated. Definition of rupture, dissection, 
and aneurysm-related death was strict, as we required in-hospital documentation by imaging studies, surgi¬ 
cal findings, or post-mortem examination. The mortality calculations are immune from this factor and 
represent true rates. Second, patients we followed were operated on electively when they reached size cri¬ 
teria, thus eliminating them from susceptibility to rupture or dissection. The only patients with very large 
aneurysms followed without surgery were those cared for elsewhere before referral to us, those refusing 
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surgery, or those felt to be non-operative candidates. These two factors —strict definition of aneurysm- 
related events, and limitation of patients at risk by pre-emptive surgery—imply that the yearly rates we 
have presented represent minimum lower limits of the actual rates. Some out of hospital deaths were cer¬ 
tainly aneurysm-related. Thus, in decision-making and counseling, we can presume that the risk of rupture 
or dissection is at least 6.4% per year for 6 cm aneurysms. On the other hand, the rupture rate cannot ex¬ 
ceed the combined endpoint rate of 14.1%, as unidentified/unrepaired rupture is a lethal event. 
Two interesting and not anticipated findings of our study are that comorbid vascular disease in¬ 
creased the risk of rupture (odds ratio > 2-fold) and that male sex provides some relative protection (odds 
ratio 0.365). The former implicates complex processes of vascular biology in the growth of aneurysms and 
their subsequent rupture. The latter suggests that women require closer scrutiny, possibly because a spe¬ 
cific size aneurysm represents proportionately greater aortic dilatation in smaller patients of female sex. 
That is, female sex may be a surrogate for low body surface area in this report. 
Another issue has to do with the influence of concomitant pulmonary disease on aortic events. 
Multiple prior studies have shown such correlation ,5i-60-65 We found an adverse impact of pulmonary disease 
on the rate of growth of the aorta, but did not confirm an impact on rupture or dissection. Regarding hy¬ 
pertension, like Griepp’s group,65 we did not uncover a direct increase in rupture or dissection. As 
previously described65 it is likely that this indicates adequate treatment of hypertension, rather than a lack 
of effect of high blood pressure on aortic growth and rupture. A prospective study with serial blood pres¬ 
sure measurements would be required to fully assess the impact of high blood pressure (as opposed to 
merely a history of hypertension) in this population. 
As would be expected, we found increasing size is more strongly associated with an increased risk 
of rupture, rather than an increased risk of dissection. Dissection may occur at smaller sizes due to other 
factors (such as connective tissue disease from Marfan syndrome or bicuspid aortic valve), whereas rupture 
appears to be a predominantly size-related event. 
The Impact of Genetic Risk Factors 
The initial results from our analysis of familial patterns of TAA were published in 1999.3 Since 
that time we have identified an additional 18 patients with nMFS familial aortic disease. Consistent with 
our previous publication and that of Biddinger et al.107 in 1997, we report a familial aggregation of thoracic 
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aortic disease in 19% of patients. Ascertainment bias likely explains the trend toward younger presentation 
in patients with nMFS familial disease and those with MFS. That is, patients with a close relative with an 
aneurysm may seek medical attention earlier than patients with sporadic TAA, and patients with MFS are 
screened for asymptomatic disease. 
Hypertension is significantly associated with thoracic aortic disease in both familial and sporadic 
patients (68.8% and 60.5%), but not in patients with MFS. Although it is well known that hypertension is 
associated with aortic aneurysms, aneurysm formation cannot be ascribed to elevated blood pressure 
alone.107 The low rate of hypertension in patients with MFS suggests that inherent vessel weakness due to 
the genetic defect in the fibrillin gene may represent the greatest influence on aneurysm formation in these 
patients. Differing levels of genetic susceptibility to aneurysm formation may be reflected in the trend to¬ 
ward increased aortic growth rates seen in patients with familial disease despite similar levels of 
hypertension. 
It was surprising to find the incidence of comorbidities to be similar in the nMFS familial and the 
sporadic cases. This may reflect the heterogeneous nature of the population described as nMFS familial. 
Some of these patients may have severe genetic defects similar to those in MFS, while others may have 
very mild genetic defects. This is consistent with the pattern seen with defects in fibrillin, since a number 
of reports have described patients with well-characterized genetic defects in fibrillin who do not manifest 
the full-spectrum of MFS.108,122 
Pedigree analysis suggests a dominant mode of inheritance with reduced penetrance. This is con¬ 
sistent with a complex disease in which disease genotype is associated with an increased susceptibility to 
as-yet-undefined environmental effects (for example, hypertension or chronic infection or inflammatory 
processes). Linkage analysis in a single family with familial nMFS disease has excluded FBN1 as a poten¬ 
tial candidate gene indicating that other genes are involved in the predisposition toward aortic aneurysm 
formation. 
Several limitations of this study should be mentioned. Long-term survival in the patients in whom 
we were able to ascertain a family history is significantly better than those who we were not able to contact. 
This suggests that we have interrogated a population with less severe disease on average. The prospective 
identification of patients following our initial publication should mitigate this effect as we continue to 
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gather patients. Because this study includes only families with previously diagnosed disease, it is likely 
that we failed to include some families with undiagnosed asymptomatic TAA and AAA. Likewise a rela¬ 
tive may have died before aneurysms became symptomatic. Because we proceeded conservatively and did 
not include patients with a history of sudden death in the family, our estimate of 19% prevalence of familial 
aggregation should be taken as a lower limit of the true prevalence. 
In order to minimize non-inclusion of asymptomatic disease, we hope to screen all first-degree 
family members of our pedigrees to identify additional patients with undetected aneurysm and to confirm 
or refute absence of aortic disease in other family members. 
Summary 
This report confirms that 19% of families demonstrate familial aggregation of thoracic aortic dis¬ 
ease. While sample sizes were too small to assess statistical significance in this population, it appears that 
patients with non-Marfan-related familial thoracic aortic disease have similar clinical and demographic 
characteristics as sporadic cases. In addition, they may have higher growth rates and a worse long-term 
survival. Larger, prospective studies need to be performed in order to assess the true risk associated with a 
family history of thoracic aortic disease. Whole genome analysis of linkage using families with a signifi¬ 
cant number of living, affected individuals will likely be required in order to establish the nature of genetic 
risk in this population. 
Our review of the natural history of thoracic aortic aneurysms prior to surgical repair permits the 
following conclusions. Thoracic aortic aneurysm is a lethal disease. Forty-six percent of patients with 
large aneurysms will die within 5 years. Aneurysm size has a profound impact on rupture, dissection, and 
death. For counseling purposes, the patient with an aneurysm exceeding 6 cm in diameter can expect a 
yearly rate of rupture or dissection of at least 6.4% and a death rate of 10.8% per year. Elective surgery 
eliminates the risk of rupture and restores survival to near normal. Elective surgical repair can be accom¬ 
plished at a “cost” of less than a single year’s expected natural mortality. Careful follow-up of patients 
with thoracic aortic aneurysms is essential, with pre-emptive extirpation before the dangerous diameter 
criterion of 6 cm. It is hoped that these data will permit concrete estimation of the natural history side of 
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